<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7533477\results\search\disease\results.xml">
  <result pre="consistent with existing copyright protections.S0317167120001730a.pdf Abstract: Background: Albeit primarily a" exact="disease" post="of respiratory tract, the 2019 coronavirus infectious disease (COVID-19)"/>
  <result pre="existing copyright protections.S0317167120001730a.pdf Abstract: Background: Albeit primarily a disease of" exact="respiratory" post="tract, the 2019 coronavirus infectious disease (COVID-19) has been"/>
  <result pre="Albeit primarily a disease of respiratory tract, the 2019 coronavirus" exact="infectious disease" post="(COVID-19) has been found to have causal association with"/>
  <result pre="primarily a disease of respiratory tract, the 2019 coronavirus infectious" exact="disease" post="(COVID-19) has been found to have causal association with"/>
  <result pre="of COVID-19 are abundant. Clinical features of both central and" exact="peripheral" post="nervous system involvement are evident. These have been categorically"/>
  <result pre="briefly with literature support. Most of the psychological effects are" exact="secondary" post="to pandemic-associated regulatory, socioeconomic and psychosocial changes. Conclusion: Neurological"/>
  <result pre="and psychosocial changes. Conclusion: Neurological and neuropsychiatric manifestations of this" exact="disease" post="are only beginning to unravel. This demands a wide"/>
  <result pre="and mortality. RÃ‰SUMÃ‰ : Les impacts neurologiques et neuropsychiatriques dâ€™une" exact="infection" post="Ã la COVID-19. Contexte : Bien quâ€™il sâ€™agisse principalement"/>
  <result pre=": Il appert que les manifestations neurologiques et neuropsychiatriques des" exact="infections" post="Ã la COVID-19 sont nombreuses. Les caractÃ©ristiques cliniques dâ€™une"/>
  <result pre="complications additionnelles et une mortalitÃ© accrue. Keywords: SARS-CoV-2 COVID-19 Neuro-COVID" exact="Axonal" post="transport Neurotropism Neurovirulence Neuroinvasion Encephalopathy Encephalitis Stroke Cerebrovascular events"/>
  <result pre="accrue. Keywords: SARS-CoV-2 COVID-19 Neuro-COVID Axonal transport Neurotropism Neurovirulence Neuroinvasion" exact="Encephalopathy" post="Encephalitis Stroke Cerebrovascular events Epilepsy Seizures Demyelination Ataxia Myelitis"/>
  <result pre="Keywords: SARS-CoV-2 COVID-19 Neuro-COVID Axonal transport Neurotropism Neurovirulence Neuroinvasion Encephalopathy" exact="Encephalitis" post="Stroke Cerebrovascular events Epilepsy Seizures Demyelination Ataxia Myelitis Myoclonus"/>
  <result pre="COVID-19 Neuro-COVID Axonal transport Neurotropism Neurovirulence Neuroinvasion Encephalopathy Encephalitis Stroke" exact="Cerebrovascular" post="events Epilepsy Seizures Demyelination Ataxia Myelitis Myoclonus Polyradiculopathy Therapeutic"/>
  <result pre="Axonal transport Neurotropism Neurovirulence Neuroinvasion Encephalopathy Encephalitis Stroke Cerebrovascular events" exact="Epilepsy" post="Seizures Demyelination Ataxia Myelitis Myoclonus Polyradiculopathy Therapeutic paradigm shift"/>
  <result pre="transport Neurotropism Neurovirulence Neuroinvasion Encephalopathy Encephalitis Stroke Cerebrovascular events Epilepsy" exact="Seizures" post="Demyelination Ataxia Myelitis Myoclonus Polyradiculopathy Therapeutic paradigm shift Psychosocial"/>
  <result pre="Neurovirulence Neuroinvasion Encephalopathy Encephalitis Stroke Cerebrovascular events Epilepsy Seizures Demyelination" exact="Ataxia" post="Myelitis Myoclonus Polyradiculopathy Therapeutic paradigm shift Psychosocial Psychiatric Addiction"/>
  <result pre="Encephalopathy Encephalitis Stroke Cerebrovascular events Epilepsy Seizures Demyelination Ataxia Myelitis" exact="Myoclonus" post="Polyradiculopathy Therapeutic paradigm shift Psychosocial Psychiatric Addiction COVID ref-count:"/>
  <result pre="Encephalitis Stroke Cerebrovascular events Epilepsy Seizures Demyelination Ataxia Myelitis Myoclonus" exact="Polyradiculopathy" post="Therapeutic paradigm shift Psychosocial Psychiatric Addiction COVID ref-count: page-count:"/>
  <result pre="page-count: Background The medical havoc wreaked by the novel severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV-2) has grown exponentially to pandemic"/>
  <result pre="Background The medical havoc wreaked by the novel severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV-2) has grown exponentially to pandemic proportions"/>
  <result pre="The medical havoc wreaked by the novel severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV-2) has grown exponentially to pandemic proportions within"/>
  <result pre="coronavirus (SARS-CoV-2) has grown exponentially to pandemic proportions within a" exact="short" post="span of time, starting in December 2019. As of"/>
  <result pre="disease.2â€&quot;4 There are burgeoning concerns of people already suffering from" exact="chronic" post="neurological ailments and of people receiving immunosuppressant therapies (IST)"/>
  <result pre="their underlying illnesses, making them more susceptible to 2019 coronavirus" exact="infectious disease" post="(COVID-19). Essential steps also need to be taken to"/>
  <result pre="underlying illnesses, making them more susceptible to 2019 coronavirus infectious" exact="disease" post="(COVID-19). Essential steps also need to be taken to"/>
  <result pre="making them more susceptible to 2019 coronavirus infectious disease (COVID-19)." exact="Essential" post="steps also need to be taken to forestall a"/>
  <result pre="also added as per context. Results/Discussion Neurotropic Properties of SARS-CoV-2" exact="Viral" post="infections of the respiratory tract, identified as a major"/>
  <result pre="added as per context. Results/Discussion Neurotropic Properties of SARS-CoV-2 Viral" exact="infections" post="of the respiratory tract, identified as a major medical"/>
  <result pre="context. Results/Discussion Neurotropic Properties of SARS-CoV-2 Viral infections of the" exact="respiratory" post="tract, identified as a major medical problem even as"/>
  <result pre="and immune-compromised individuals.5â€&quot;7 Children are more susceptible, often experiencing multiple" exact="infections" post="every year till the age of 10.8 The respiratory"/>
  <result pre="multiple infections every year till the age of 10.8 The" exact="respiratory" post="epithelium, first line of defense against pathogens, often serves"/>
  <result pre="defense against pathogens, often serves as a target for different" exact="respiratory" post="viruses to percolate into human host. Infections can remain"/>
  <result pre="target for different respiratory viruses to percolate into human host." exact="Infections" post="can remain self-limited and localized or can progress to"/>
  <result pre="to percolate into human host. Infections can remain self-limited and" exact="localized" post="or can progress to more severe respiratory diseases9 or"/>
  <result pre="remain self-limited and localized or can progress to more severe" exact="respiratory" post="diseases9 or even spread to other tissues, including the"/>
  <result pre="respiratory diseases9 or even spread to other tissues, including the" exact="central nervous system" post="(CNS), where they could induce other types of pathologies,10"/>
  <result pre="of the host immune response. Over the years, several different" exact="respiratory" post="viruses have been shown to be able to penetrate"/>
  <result pre="induction of neurological diseases (neurovirulence).11 Some common pathogens include the" exact="respiratory" post="syncytial virus, measles virus, influenza virus, West Nile Virus,"/>
  <result pre="diseases (neurovirulence).11 Some common pathogens include the respiratory syncytial virus," exact="measles" post="virus, influenza virus, West Nile Virus, emerging pathogens such"/>
  <result pre="are further classified within four different genera, namely Alpha, Beta," exact="Gamma" post="and Delta coronaviruses.17,18 However, it has now been proven"/>
  <result pre="possesses an acetyl-esterase function, which may be important during early" exact="infection" post="or during the release of viral particles from the"/>
  <result pre="be important during early infection or during the release of" exact="viral" post="particles from the infected cells at the end of"/>
  <result pre="variety of animal species, mostly exhibiting selective tropism towards the" exact="respiratory" post="tract or the gut. Notably, some among these, the"/>
  <result pre="Notably, some among these, the feline coronavirus and porcine hemagglutinating" exact="encephalitis" post="virus variants, have also been implicated in neurological diseases,"/>
  <result pre="to the nervous system predominantly by two routes: hematogenous or" exact="neuronal" post="transmission. Hematogenous Route SARS-CoV-2 may infect the endothelial cells"/>
  <result pre="aminopeptidase-N.35 Similar findings have also been demonstrated by SARS-CoV.34,36,37 Following" exact="infection" post="of these cell lines, monocytes get activated, differentiate into"/>
  <result pre="other tissues, including the nervous system.27,32,33,36 On the other hand," exact="infection" post="of dendritic cells results in wavering of innate immunity,"/>
  <result pre="results in wavering of innate immunity, and further perpetuating spread.37" exact="Neuronal" post="Route This occurs when the virus infects peripheral nerves"/>
  <result pre="perpetuating spread.37 Neuronal Route This occurs when the virus infects" exact="peripheral" post="nerves and enters the CNS in a retrograde manner"/>
  <result pre="virus infects peripheral nerves and enters the CNS in a" exact="retrograde" post="manner via active axonal transport.38 Once in the brain,"/>
  <result pre="and enters the CNS in a retrograde manner via active" exact="axonal" post="transport.38 Once in the brain, for example, HCoV-OC43 has"/>
  <result pre="because of misdirected host immune responses and/or direct damage to" exact="neuronal" post="cells by replicating viral particles as in acute encephalitis.21"/>
  <result pre="immune responses and/or direct damage to neuronal cells by replicating" exact="viral" post="particles as in acute encephalitis.21 Possible Mechanisms of Neurovirulence"/>
  <result pre="damage to neuronal cells by replicating viral particles as in" exact="acute" post="encephalitis.21 Possible Mechanisms of Neurovirulence of SARS-CoV-2 Hypoxia-Related Neurovirulence"/>
  <result pre="Possible Mechanisms of Neurovirulence of SARS-CoV-2 Hypoxia-Related Neurovirulence Firstly, the" exact="respiratory" post="tract, being the most commonly and severely affected system,"/>
  <result pre="often leads to hypoxia, which may subsequently result in hypoxic" exact="brain" post="injuries.39 Inflammation-Related Neurovirulence The viral infection is also known"/>
  <result pre="may subsequently result in hypoxic brain injuries.39 Inflammation-Related Neurovirulence The" exact="viral infection" post="is also known to propagate via a cytokine storm"/>
  <result pre="subsequently result in hypoxic brain injuries.39 Inflammation-Related Neurovirulence The viral" exact="infection" post="is also known to propagate via a cytokine storm"/>
  <result pre="propagate via a cytokine storm responsible for its clinical features.40" exact="Inflammatory" post="injury to the nervous system thus does not seem"/>
  <result pre="tissue, thus making them more susceptible to injury leading to" exact="encephalitis" post="or myelitis.41 There have been reported cases of intracerebral"/>
  <result pre="intracerebral hemorrhages occurring due to SARS-CoV-2, also attributable to the" exact="viral" post="binding to ACE-2 present in the cerebral blood vessels,"/>
  <result pre="attributable to the viral binding to ACE-2 present in the" exact="cerebral" post="blood vessels, thus raising luminal pressure.42 Similarly, binding to"/>
  <result pre="to the viral binding to ACE-2 present in the cerebral" exact="blood vessels," post="thus raising luminal pressure.42 Similarly, binding to these receptors"/>
  <result pre="within the nervous system.43 ACE-1 is known to result in" exact="neuronal" post="damage, inflammation, degeneration and death of neurons.43 Notably, these"/>
  <result pre="of SARS-CoV-2 to which would lead to widespread endothelial dysfunction," exact="systemic" post="endotheliitis associated with apoptosis, culminating in neuronal cell death."/>
  <result pre="widespread endothelial dysfunction, systemic endotheliitis associated with apoptosis, culminating in" exact="neuronal" post="cell death. The presence of viral elements inside endothelial"/>
  <result pre="with apoptosis, culminating in neuronal cell death. The presence of" exact="viral" post="elements inside endothelial cells substantiates the hypothesis of a"/>
  <result pre="included five cases of large-vessel ischemic stroke, three cases of" exact="axonal" post="polyneuropathy, two cases of myopathy and three cases of"/>
  <result pre="ischemic stroke, three cases of axonal polyneuropathy, two cases of" exact="myopathy" post="and three cases of rhabdomyolysis, all of them occurring"/>
  <result pre="2003 SARS epidemic caused by SARS-CoV. There was evidence of" exact="muscle" post="weakness and raised creatine kinase levels in patients who"/>
  <result pre="were considered to belong to the spectrum of critical illness" exact="neuropathy" post="and myopathy or developing as a result of steroid"/>
  <result pre="considered to belong to the spectrum of critical illness neuropathy" exact="and myopathy" post="or developing as a result of steroid use or"/>
  <result pre="to belong to the spectrum of critical illness neuropathy and" exact="myopathy" post="or developing as a result of steroid use or"/>
  <result pre="developing as a result of steroid use or cachectic disuse" exact="atrophy" post="and weakness following long-term bed rest.46,47 Autopsy studies in"/>
  <result pre="weakness following long-term bed rest.46,47 Autopsy studies in patients showed" exact="cerebral edema," post="meningeal vasodilatation, lymphocytic infiltration and ischemic demyelination of neurons;"/>
  <result pre="lymphocytic infiltration and ischemic demyelination of neurons; in some instances," exact="viral" post="particles and genome sequences of SARS-CoV were detected.48â€&quot;51 Middle"/>
  <result pre="particles and genome sequences of SARS-CoV were detected.48â€&quot;51 Middle East" exact="respiratory" post="syndrome, caused by MERS-CoV (in 2012), is also known"/>
  <result pre="be potentially neuroinvasive with features ranging from altered mentation, confusion," exact="ataxia" post="and ophthalmoplegia to focal neurological deficits and coma.52 Radiological"/>
  <result pre="neuroinvasive with features ranging from altered mentation, confusion, ataxia and" exact="ophthalmoplegia" post="to focal neurological deficits and coma.52 Radiological findings have"/>
  <result pre="features ranging from altered mentation, confusion, ataxia and ophthalmoplegia to" exact="focal" post="neurological deficits and coma.52 Radiological findings have been shown"/>
  <result pre="intracerebral hemorrhages, ischemic strokes to encephalitic features.52 Involvement of the" exact="peripheral" post="nervous system in the form of Guillainâ€&quot;BarrÃ© syndrome (GBS)"/>
  <result pre="of the peripheral nervous system in the form of Guillainâ€&quot;BarrÃ©" exact="syndrome" post="(GBS) and critical illness polyneuropathy have also been reported.52"/>
  <result pre="nervous system in the form of Guillainâ€&quot;BarrÃ© syndrome (GBS) and" exact="critical illness polyneuropathy" post="have also been reported.52 In a retrospective study by"/>
  <result pre="in the form of Guillainâ€&quot;BarrÃ© syndrome (GBS) and critical illness" exact="polyneuropathy" post="have also been reported.52 In a retrospective study by"/>
  <result pre="in 2014, CNS manifestations in the form of confusion, headache" exact="and seizures" post="were noted in 25.7%, 12.9% and 8.6% of patients,"/>
  <result pre="2014, CNS manifestations in the form of confusion, headache and" exact="seizures" post="were noted in 25.7%, 12.9% and 8.6% of patients,"/>
  <result pre="the world, more and more neurological manifestations involving central and" exact="peripheral" post="nervous systems as well as skeletal muscles are coming"/>
  <result pre="retrospective study from Wuhan, 6% of infected hospitalized patients developed" exact="acute" post="cerebrovascular events following COVID-19 infection.54 Outside China, a study"/>
  <result pre="have shown neurologic involvement as the presenting feature of SARS-CoV-2" exact="infection" post="or have reported post-infectious neurologic complications.3,42,56â€&quot;58 Broadly speaking, these"/>
  <result pre="the part of the neuroaxis involved, namely CNS manifestations and" exact="peripheral" post="nervous system involvement, including skeletal muscle injury. CNS Manifestations"/>
  <result pre="namely CNS manifestations and peripheral nervous system involvement, including skeletal" exact="muscle" post="injury. CNS Manifestations Headache and Dizziness Several studies considered"/>
  <result pre="headache.3 Although mostly considered a rather non-specific symptom of any" exact="viral infection," post="headache has been largely present in most studies conducted"/>
  <result pre="some studies.3,4,59â€&quot;61 Nevertheless, headache can often be a forerunner of" exact="viral meningitis" post="or encephalitis and is often the premonitory symptom of"/>
  <result pre="studies.3,4,59â€&quot;61 Nevertheless, headache can often be a forerunner of viral" exact="meningitis" post="or encephalitis and is often the premonitory symptom of"/>
  <result pre="headache can often be a forerunner of viral meningitis or" exact="encephalitis" post="and is often the premonitory symptom of a cerebrovascular"/>
  <result pre="SARS-CoV-2 entry: ACE-2 and transmembrane protease serine-2.69 In contrast, olfactory" exact="epithelial" post="support cells and stem cells are found to express"/>
  <result pre="found to express both, as do cells in the nasal" exact="respiratory" post="epithelium.69 Based on these findings, Brann etÂ al.69 have"/>
  <result pre="findings, Brann etÂ al.69 have postulated several plausible mechanisms of" exact="viral" post="entry into the olfactory epithelium. Firstly, local infection of"/>
  <result pre="mechanisms of viral entry into the olfactory epithelium. Firstly, local" exact="infection" post="of the vascular and sustentacular cells in the nasal"/>
  <result pre="entry into the olfactory epithelium. Firstly, local infection of the" exact="vascular" post="and sustentacular cells in the nasal epithelium could result"/>
  <result pre="indirectly influencing signalling from olfactory sensory neurons to the brain.69" exact="Vascular" post="damage causing hypoperfusion may also be responsible for olfactory"/>
  <result pre="mucosal epithelium, thus proving an entry source to the virus.70" exact="Cerebrovascular" post="Events A much more crucial area of thought, which"/>
  <result pre="a longer duration of hospital stay, almost always associated with" exact="acute" post="respiratory distress syndrome (ARDS) and associated with a poorer"/>
  <result pre="longer duration of hospital stay, almost always associated with acute" exact="respiratory" post="distress syndrome (ARDS) and associated with a poorer overall"/>
  <result pre="of hospital stay, almost always associated with acute respiratory distress" exact="syndrome" post="(ARDS) and associated with a poorer overall outcome.74,75 Predictably"/>
  <result pre="A larger proportion of this subset were shown to have" exact="acute" post="ischemic stroke, with only one patient having an intracerebral"/>
  <result pre="have acute ischemic stroke, with only one patient having an" exact="intracerebral hemorrhage" post="(ICH), who succumbed subsequently to respiratory failure.4 In divergent"/>
  <result pre="patient having an intracerebral hemorrhage (ICH), who succumbed subsequently to" exact="respiratory" post="failure.4 In divergent studies conducted across China during this"/>
  <result pre="as 17%.3,60,76â€&quot;79 Predictably enough, the larger proportion of these were" exact="acute" post="ischemic stroke.54 In a single-centre observational study from China,"/>
  <result pre="China, apart from the 5% of COVID-19 patients who had" exact="acute" post="ischemic stroke, cerebral venous sinus thrombosis and ICH were"/>
  <result pre="the 5% of COVID-19 patients who had acute ischemic stroke," exact="cerebral" post="venous sinus thrombosis and ICH were also documented in"/>
  <result pre="COVID-19 patients who had acute ischemic stroke, cerebral venous sinus" exact="thrombosis" post="and ICH were also documented in one patient each.54"/>
  <result pre="also documented in one patient each.54 Thirty-eight per cent of" exact="total" post="deaths in this study occurred due to cerebrovascular events."/>
  <result pre="mighty 62% of patients presented with cerebrovascular events, 74% with" exact="acute" post="ischemic stroke and 12% with ICH, and one patient"/>
  <result pre="of patients presented with cerebrovascular events, 74% with acute ischemic" exact="stroke" post="and 12% with ICH, and one patient with CNS"/>
  <result pre="were noted in older patients, having multiple comorbidities, mainly hypertension," exact="diabetes" post="and prior stroke. They had a severe course of"/>
  <result pre="aged &amp;lt;50 years, sometimes occurring earlier in the course of" exact="viral infection" post="as compared to an average duration of 10â€&quot;12 d61,84"/>
  <result pre="&amp;lt;50 years, sometimes occurring earlier in the course of viral" exact="infection" post="as compared to an average duration of 10â€&quot;12 d61,84"/>
  <result pre="by Mao etÂ al.4 It has also been noted that" exact="stroke" post="patients who were positive for COVID-19 had significantly higher"/>
  <result pre="positive for COVID-19 had significantly higher in-hospital mortality, incidences of" exact="delirium" post="and a greater morbidity compared to those without COVID-19.85"/>
  <result pre="without COVID-19.85 Research has proved, time and again, that recent" exact="viral" post="or bacterial infection is quite a plausible cause of"/>
  <result pre="Research has proved, time and again, that recent viral or" exact="bacterial infection" post="is quite a plausible cause of cerebrovascular ischemia,84 and"/>
  <result pre="has proved, time and again, that recent viral or bacterial" exact="infection" post="is quite a plausible cause of cerebrovascular ischemia,84 and"/>
  <result pre="the given circumstances that we consider the linkage of COVID-19" exact="infection" post="with the occurrence of coagulopathy and increased risk of"/>
  <result pre="consider the linkage of COVID-19 infection with the occurrence of" exact="coagulopathy" post="and increased risk of thrombotic events. Several cases of"/>
  <result pre="elusive. There are significant data suggesting the development of a" exact="systemic" post="inflammatory response syndrome in these patients. There is substantial"/>
  <result pre="significant data suggesting the development of a systemic inflammatory response" exact="syndrome" post="in these patients. There is substantial proof that increased"/>
  <result pre="substantial proof that increased severity of illness and risk of" exact="thrombosis" post="is invariably associated with a higher level of C-reactive"/>
  <result pre="of inflammation.86â€&quot;89 On the other hand, SARS-CoV-2, being primarily a" exact="respiratory" post="pathogen, induces fatal hypoxemia in the most severe cases."/>
  <result pre="cases. This again may result in vasoconstriction, reduced blood flow," exact="vascular" post="stasis and vessel occlusion.86â€&quot;89 Another feasible theory lies in"/>
  <result pre="etÂ al.87 also had 87.7% of patients testing positive for" exact="lupus" post="anticoagulant (LA), which is an anti-phospholipid antibody. It was"/>
  <result pre="in dilute Russell Viper venom reagents. Cellular damage due to" exact="infection" post="possibly causes plasma membrane remodelling and exposure of otherwise"/>
  <result pre="presence is known to enhance both arterial and venous thromboses.87" exact="Meningoencephalitis" post="and Encephalopathy A potentially fatal presentation of SARS-CoV-2 is"/>
  <result pre="known to enhance both arterial and venous thromboses.87 Meningoencephalitis and" exact="Encephalopathy" post="A potentially fatal presentation of SARS-CoV-2 is the development"/>
  <result pre="development of encephalopathy. Symptoms may range from mere headache, fever" exact="and neck" post="rigidity to more sinister signs of brain involvement like"/>
  <result pre="headache, fever and neck rigidity to more sinister signs of" exact="brain" post="involvement like altered sensorium, agitation, seizures, coma or even"/>
  <result pre="brain involvement like altered sensorium, agitation, seizures, coma or even" exact="focal" post="neurological deficits. One of the first cases of viral"/>
  <result pre="even focal neurological deficits. One of the first cases of" exact="viral encephalitis" post="was reported from Japan,90 where a 24-year-old man presented"/>
  <result pre="focal neurological deficits. One of the first cases of viral" exact="encephalitis" post="was reported from Japan,90 where a 24-year-old man presented"/>
  <result pre="sought medical care for non-specific symptoms of fever and fatigue." exact="Brain" post="imaging showed signs of right lateral ventriculitis and encephalitis,"/>
  <result pre="lateral ventriculitis and encephalitis, primarily centered on the right mesial" exact="temporal lobe" post="and hippocampal region.90 Interestingly, SARS-CoV-2 RNA was detected in"/>
  <result pre="was detected in his CSF, but nasopharyngeal swabs remained negative.90" exact="Encephalitis" post="as a clinical manifestation of COVID-19 has been reported"/>
  <result pre="by many since then.91â€&quot;96 Early in April 2020, a young" exact="female" post="from Los Angeles was diagnosed with SARS-CoV-2 encephalitis.96 It"/>
  <result pre="show any response to the usually followed treatment protocols for" exact="viral" post="meningoencephalitis that COVID-19 testing was ordered.96 She was started"/>
  <result pre="any response to the usually followed treatment protocols for viral" exact="meningoencephalitis" post="that COVID-19 testing was ordered.96 She was started on"/>
  <result pre="showing improvement in her clinical picture.96 One putative mechanism of" exact="viral encephalitis" post="could be a direct invasion of the CNS by"/>
  <result pre="improvement in her clinical picture.96 One putative mechanism of viral" exact="encephalitis" post="could be a direct invasion of the CNS by"/>
  <result pre="to believe a possible hypothesis of immune-mediated inflammatory injury and" exact="cerebral oedema" post="to be responsible for such encephalopathic changes.91 Encephalopathy in"/>
  <result pre="and cerebral oedema to be responsible for such encephalopathic changes.91" exact="Encephalopathy" post="in patients with COVID-19 does not involve a diagnosis"/>
  <result pre="in patients with COVID-19 does not involve a diagnosis of" exact="viral encephalitis." post="Other causes behind an encephalopathy-like clinical presentation â€&quot; replete"/>
  <result pre="consciousness, agitation or signs of corticospinal tract involvement â€&quot; are" exact="acute" post="toxic encephalopathies, metabolic imbalances, hypoxic encephalopathies, strokes, as discussed"/>
  <result pre="encephalopathies, metabolic imbalances, hypoxic encephalopathies, strokes, as discussed above, or" exact="seizures" post="with post-ictal confusion. Helms etÂ al.55 noted agitation in"/>
  <result pre="showed confusion of varying degrees, and 67% of cases demonstrated" exact="diffuse" post="corticospinal tract signs.55 Subsequently, 13 of them were subjected"/>
  <result pre="to a specific etiology are still inconclusive. Elderly patients with" exact="chronic" post="underlying conditions or prior neurological ailments have been seen"/>
  <result pre="neurological ailments have been seen to suffer from more severe" exact="infection" post="and are at a greater risk of encephalopathy at"/>
  <result pre="more severe infection and are at a greater risk of" exact="encephalopathy" post="at initial presentation.55 Reportedly, children are being considered to"/>
  <result pre="a less severe form of SARS-CoV-2.98 An index case of" exact="acute" post="hemorrhagic necrotising encephalopathy, most likely due to cytokine storm"/>
  <result pre="the setting of SARS-CoV-2, has been described.93 Another case of" exact="acute" post="necrotising encephalitis has been reported by Virhammer etÂ al.99"/>
  <result pre="of SARS-CoV-2, has been described.93 Another case of acute necrotising" exact="encephalitis" post="has been reported by Virhammer etÂ al.99 wherein SARS-CoV-2"/>
  <result pre="the part of the neurologist to keep in mind SARS-CoV-2" exact="infections" post="while dealing with such cases as expeditious isolation of"/>
  <result pre="is deemed indispensable to stall further spread of the infection." exact="Seizures" post="and SARS-CoV-2 A rather sinister complication of COVID-19 is"/>
  <result pre="the occurrence of seizures, which often heralds a grim outcome.100" exact="Seizures" post="can occur because of encephalitis, electrolyte disturbances and metabolic/hypoxic/toxic"/>
  <result pre="disturbances and metabolic/hypoxic/toxic encephalopathy. Effects of COVID-19 on patients with" exact="epilepsy" post="and whether it increases the risk of contracting infection"/>
  <result pre="with epilepsy and whether it increases the risk of contracting" exact="infection" post="remain unclear as of now. No definite association between"/>
  <result pre="infection remain unclear as of now. No definite association between" exact="epilepsy" post="and COVID-19 has been reported. However, fever itself is"/>
  <result pre="COVID-19 has been reported. However, fever itself is known to" exact="lower" post="seizure thresholds and hence can precipitate convulsions in a"/>
  <result pre="has been reported. However, fever itself is known to lower" exact="seizure" post="thresholds and hence can precipitate convulsions in a known"/>
  <result pre="and hence can precipitate convulsions in a known patient with" exact="epilepsy" post="syndromes.100 A study conducted by Lu etÂ al.100 in"/>
  <result pre="304 patients of SARS-CoV-2 infection, 84 (27%) showed evidences of" exact="systemic" post="or direct cerebral involvement that increased chances of developing"/>
  <result pre="SARS-CoV-2 infection, 84 (27%) showed evidences of systemic or direct" exact="cerebral" post="involvement that increased chances of developing a new-onset seizure"/>
  <result pre="direct cerebral involvement that increased chances of developing a new-onset" exact="seizure" post="or status epilepticus, the most common etiology being hypoxemia"/>
  <result pre="involvement that increased chances of developing a new-onset seizure or" exact="status epilepticus," post="the most common etiology being hypoxemia (77%).100 However, clinical"/>
  <result pre="seizures.100 Mao etÂ al.4 reported only a single case with" exact="seizures" post="in their study. Only three other case reports of"/>
  <result pre="RNA was however undetected in CSF, serum or plasma.101 Possibly," exact="seizures" post="resulted as a cause of febrile illness, although rhinoviral-induced"/>
  <result pre="not be ruled out with certainty.101 Vollono etÂ al.102 reported" exact="focal" post="status epilepticus as the presenting feature of the second"/>
  <result pre="be ruled out with certainty.101 Vollono etÂ al.102 reported focal" exact="status epilepticus" post="as the presenting feature of the second case, who"/>
  <result pre="incidentally was on antiepileptic drugs for a prior history of" exact="herpes" post="encephalitis. Though she tested positive for SARS-CoV-2 on nasopharyngeal"/>
  <result pre="be ascertained.102 The most suitable rationale is that a mounting" exact="systemic" post="response to the viral infection triggered this status.102 Non-compliance"/>
  <result pre="suitable rationale is that a mounting systemic response to the" exact="viral infection" post="triggered this status.102 Non-compliance to medication could be a"/>
  <result pre="rationale is that a mounting systemic response to the viral" exact="infection" post="triggered this status.102 Non-compliance to medication could be a"/>
  <result pre="probability.102 The third case was the previously mentioned case of" exact="encephalitis" post="documented by Moriguchi etÂ al.90 who presented with new-onset"/>
  <result pre="encephalitis documented by Moriguchi etÂ al.90 who presented with new-onset" exact="seizures" post="with a positive CSF sample for SARS-CoV-2 RNA. Albeit"/>
  <result pre="for SARS-CoV-2 RNA. Albeit some studies have reported incidences of" exact="viral" post="infections associated with sudden unexplained/unexpected deaths in epilepsy,103,104 such"/>
  <result pre="SARS-CoV-2 RNA. Albeit some studies have reported incidences of viral" exact="infections" post="associated with sudden unexplained/unexpected deaths in epilepsy,103,104 such associations"/>
  <result pre="epilepsy,103,104 such associations with COVID-19 are yet to be demonstrated." exact="Cerebellar Ataxia" post="in SARS-CoV-2 A rather uncommon manifestation of CNS involvement"/>
  <result pre="such associations with COVID-19 are yet to be demonstrated. Cerebellar" exact="Ataxia" post="in SARS-CoV-2 A rather uncommon manifestation of CNS involvement"/>
  <result pre="from Wuhan in the early times of the pandemic reported" exact="ataxia" post="in only one of their cases.4 However, the apparent"/>
  <result pre="Lahiri etÂ al.105 reported a 72-year-old patient presenting with acute-onset" exact="cerebellar ataxia" post="followed by encephalopathy. Neurological manifestation in this case was"/>
  <result pre="etÂ al.105 reported a 72-year-old patient presenting with acute-onset cerebellar" exact="ataxia" post="followed by encephalopathy. Neurological manifestation in this case was"/>
  <result pre="case was antecedent to a diagnosis of SARS-CoV-2 infection.105 Post-viral" exact="acute" post="cerebellar ataxia is quite familiar in history and is"/>
  <result pre="was antecedent to a diagnosis of SARS-CoV-2 infection.105 Post-viral acute" exact="cerebellar ataxia" post="is quite familiar in history and is often seen"/>
  <result pre="antecedent to a diagnosis of SARS-CoV-2 infection.105 Post-viral acute cerebellar" exact="ataxia" post="is quite familiar in history and is often seen"/>
  <result pre="not far-fetched. It does need contemplation, given that patients developing" exact="ataxia" post="will need caregiver support to maintain ambulatory autonomy, which"/>
  <result pre="ambulatory autonomy, which can be a potential problem at present." exact="Myoclonus" post="in SARS-CoV-2 In a recent study, RÃ¡bano-SuÃ¡rez etÂ al.108"/>
  <result pre="a recent study, RÃ¡bano-SuÃ¡rez etÂ al.108 reported three cases of" exact="hypersomnia" post="and generalized myoclonus in COVID-19, which responded to immunotherapy."/>
  <result pre="in COVID-19, which responded to immunotherapy. Another patient suffered from" exact="bilateral" post="myoclonus without impairment of consciousness instigated by underlying electrolyte"/>
  <result pre="myoclonus without impairment of consciousness instigated by underlying electrolyte disturbances.100" exact="Spinal" post="Cord Involvement in COVID-19 Data regarding spinal cord involvement"/>
  <result pre="in COVID-19 Data regarding spinal cord involvement are scarce. Post-infectious" exact="myelitis" post="is not uncommon with several organisms ascribable to its"/>
  <result pre="cause, Mycoplasma pneumoniae being the most common.109 Myelitis following an" exact="infection" post="with Epstein-Barr virus, cytomegalovirus, measles virus or rhinovirus is"/>
  <result pre="most common.109 Myelitis following an infection with Epstein-Barr virus, cytomegalovirus," exact="measles" post="virus or rhinovirus is common. CoV-OC43 has been associated"/>
  <result pre="virus or rhinovirus is common. CoV-OC43 has been associated with" exact="acute" post="disseminated encephalomyelitis.50 Since all coronaviruses share a structural homology"/>
  <result pre="to cause similar spinal cord involvement. Only one case of" exact="acute" post="myelitis following COVID-19 infection has been described from Wuhan"/>
  <result pre="cause similar spinal cord involvement. Only one case of acute" exact="myelitis" post="following COVID-19 infection has been described from Wuhan hitherto.110"/>
  <result pre="cord involvement. Only one case of acute myelitis following COVID-19" exact="infection" post="has been described from Wuhan hitherto.110 It is only"/>
  <result pre="ACE-2 receptors present on spinal cord neurons as well.110 Peripheral" exact="Nervous System" post="Involvement Myopathy and SARS-CoV-2 Skeletal muscle damage (myopathy) in"/>
  <result pre="on spinal cord neurons as well.110 Peripheral Nervous System Involvement" exact="Myopathy" post="and SARS-CoV-2 Skeletal muscle damage (myopathy) in association with"/>
  <result pre="as well.110 Peripheral Nervous System Involvement Myopathy and SARS-CoV-2 Skeletal" exact="muscle" post="damage (myopathy) in association with SARS-CoV-2 infection has been"/>
  <result pre="and SARS-CoV-2 Skeletal muscle damage (myopathy) in association with SARS-CoV-2" exact="infection" post="has been observed to range from asymptomatic rises in"/>
  <result pre="fatigue are common symptoms of SARS-CoV-2 as with any other" exact="viral" post="illness, reported in 11â€&quot;70% of patients with COVID-19.2â€&quot;4,59,60 Even"/>
  <result pre="11â€&quot;70% of patients with COVID-19.2â€&quot;4,59,60 Even though rare, instances of" exact="rhabdomyolysis" post="have also been reported in this pandemic, one as"/>
  <result pre="reported in this pandemic, one as a late complication of" exact="viral" post="infection111 and the other as a presenting feature.111,112 Both"/>
  <result pre="creatine kinase.111,112 Mechanisms of injury could be multifarious111,112: (1) direct" exact="viral" post="invasion via ACE-2 receptors, (2) damage to muscle cell"/>
  <result pre="(1) direct viral invasion via ACE-2 receptors, (2) damage to" exact="muscle" post="cell membranes by circulating viral toxins and (3) a"/>
  <result pre="ACE-2 receptors, (2) damage to muscle cell membranes by circulating" exact="viral" post="toxins and (3) a strong cytokine-mediated immune response (â€œcytokine"/>
  <result pre="and (3) a strong cytokine-mediated immune response (â€œcytokine stormâ€�) causing" exact="muscle" post="damage. Underlying hepatic and renal disease are a risk"/>
  <result pre="cytokine-mediated immune response (â€œcytokine stormâ€�) causing muscle damage. Underlying hepatic" exact="and renal disease" post="are a risk factor for skeletal muscle damage, and"/>
  <result pre="immune response (â€œcytokine stormâ€�) causing muscle damage. Underlying hepatic and" exact="renal disease" post="are a risk factor for skeletal muscle damage, and"/>
  <result pre="response (â€œcytokine stormâ€�) causing muscle damage. Underlying hepatic and renal" exact="disease" post="are a risk factor for skeletal muscle damage, and"/>
  <result pre="hepatic and renal disease are a risk factor for skeletal" exact="muscle" post="damage, and this damage further deters their functioning.111,112 It"/>
  <result pre="damage further deters their functioning.111,112 It is important to treat" exact="rhabdomyolysis" post="with adequate fluid resuscitation to prevent acute renal shutdown,"/>
  <result pre="important to treat rhabdomyolysis with adequate fluid resuscitation to prevent" exact="acute" post="renal shutdown, keeping in mind that excessive fluid can"/>
  <result pre="keeping in mind that excessive fluid can worsen hypoxemia and" exact="respiratory" post="failure.111,112 SARS-CoV-2 Infection and Critical Illness Neuropathy/Critical Illness Myopathy"/>
  <result pre="that excessive fluid can worsen hypoxemia and respiratory failure.111,112 SARS-CoV-2" exact="Infection" post="and Critical Illness Neuropathy/Critical Illness Myopathy A growing concern"/>
  <result pre="and respiratory failure.111,112 SARS-CoV-2 Infection and Critical Illness Neuropathy/Critical Illness" exact="Myopathy" post="A growing concern regards the development of critical illness"/>
  <result pre="Myopathy A growing concern regards the development of critical illness" exact="neuropathy" post="and critical illness myopathy in patients with severe SARS-CoV-2"/>
  <result pre="regards the development of critical illness neuropathy and critical illness" exact="myopathy" post="in patients with severe SARS-CoV-2 infection requiring mechanical ventilation."/>
  <result pre="neuropathy and critical illness myopathy in patients with severe SARS-CoV-2" exact="infection" post="requiring mechanical ventilation. The use of non-depolarising neuromuscular blocking"/>
  <result pre="associated with an increased risk of critical illness neuropathy/critical illness" exact="myopathy" post="and should be administered with caution.113 Disuse atrophy and"/>
  <result pre="neuropathy/critical illness myopathy and should be administered with caution.113 Disuse" exact="atrophy" post="and resultant weakness due to damage to type 2"/>
  <result pre="caution.113 Disuse atrophy and resultant weakness due to damage to" exact="type 2" post="muscle fibres are common in patients bedridden for prolonged"/>
  <result pre="atrophy and resultant weakness due to damage to type 2" exact="muscle" post="fibres are common in patients bedridden for prolonged periods,"/>
  <result pre="be worrisome for neurologists in the coming days.113 COVID-19 and" exact="Polyradiculopathy" post="There is a known risk of GBS, often succeeding"/>
  <result pre="Epstein-Barr virus, among others.114 Rare instances of GBS following coronaviral" exact="infections" post="in previous epidemics are also apparent,52 the principle behind"/>
  <result pre="principle behind this being an act of molecular mimicry between" exact="viral" post="proteins and proteins on peripheral nerves (e.g. gangliosides). This"/>
  <result pre="act of molecular mimicry between viral proteins and proteins on" exact="peripheral" post="nerves (e.g. gangliosides). This subsequently leads to an immune"/>
  <result pre="and a resultant autoantibody-mediated damage to myelin or axons of" exact="peripheral" post="nerves. Since the reporting of the first case by"/>
  <result pre="al.58 from Wuhan, several cases of GBS related to SARS-CoV-2" exact="infection" post="have been reported so far.57,58,115â€&quot;120 Toscano etÂ al.115 described"/>
  <result pre="reported so far.57,58,115â€&quot;120 Toscano etÂ al.115 described three cases of" exact="axonal" post="and two of the demyelinating variants of GBS, respectively,"/>
  <result pre="al.115 described three cases of axonal and two of the" exact="demyelinating" post="variants of GBS, respectively, from three hospitals in northern"/>
  <result pre="note that, in a handful of these cases, the supposedly" exact="autoimmune" post="process overlapped with the viral infection, thus giving rise"/>
  <result pre="of these cases, the supposedly autoimmune process overlapped with the" exact="viral infection," post="thus giving rise to ideas reckoning the para-infectious nature"/>
  <result pre="giving rise to ideas reckoning the para-infectious nature of the" exact="disease" post="rather than it being post-infectious.120 Cases of COVID-19 presenting"/>
  <result pre="post-infectious.120 Cases of COVID-19 presenting with ophthalmoparesis from multiple cranial" exact="nerve" post="palsies and Miller-Fisher (MFS) variant of GBS have been"/>
  <result pre="COVID-19 presenting with ophthalmoparesis from multiple cranial nerve palsies and" exact="Miller-Fisher" post="(MFS) variant of GBS have been reported.121,122 Anti-Gd-1b antibodies"/>
  <result pre="is too early to conclude any definite association between SARS-CoV-2" exact="infection" post="and this milder variety of MFS.121 RT-PCR tests done"/>
  <result pre="negative, hence perpetuating our previous knowledge about MFS being an" exact="autoimmune" post="process rather than resulting from a direct viral invasion.121,122"/>
  <result pre="being an autoimmune process rather than resulting from a direct" exact="viral" post="invasion.121,122 Finsterer etÂ al.124 claimed that SARS-CoV-2 infection-induced GBS"/>
  <result pre="etÂ al.3 showed that 15% of their cohort had prior" exact="cerebrovascular accident," post="and 11% of them suffered a more severe illness"/>
  <result pre="multi-data-based study conducted in the Unites States showed patients with" exact="multiple sclerosis" post="(MS) had a higher incidence of contracting infections compared"/>
  <result pre="with multiple sclerosis (MS) had a higher incidence of contracting" exact="infections" post="compared to non-MS people.127 The crude rate of infections"/>
  <result pre="contracting infections compared to non-MS people.127 The crude rate of" exact="infections" post="was higher in those taking interferon-beta and glatiramer acetate,"/>
  <result pre="higher in those taking fingolimod, natalizumab or rituximab.127 Consequently, COVID-19" exact="infection" post="was diagnosed in an MS patient under treatment with"/>
  <result pre="patient under treatment with fingolimod in May 2020 from Iran.128" exact="Severity of" post="the underlying illness also contributes to this accentuated risk."/>
  <result pre="contributes to this accentuated risk. Neuromuscular diseases not involving the" exact="respiratory" post="muscles, for instance, seem to be at a lower"/>
  <result pre="the respiratory muscles, for instance, seem to be at a" exact="lower" post="risk. Patients with Alzheimerâ€™s disease and other types of"/>
  <result pre="seem to be at a lower risk. Patients with Alzheimerâ€™s" exact="disease" post="and other types of dementia are at a greater"/>
  <result pre="lower risk. Patients with Alzheimerâ€™s disease and other types of" exact="dementia" post="are at a greater threat, given their advanced age,"/>
  <result pre="is how COVID-19 affects patients with an underlying neurological illness." exact="Infections" post="are known to unmask or exacerbate several autoimmune neuromuscular"/>
  <result pre="neurological illness. Infections are known to unmask or exacerbate several" exact="autoimmune" post="neuromuscular diseases, viz. myasthenia gravis, chronic inflammatory demyelinating polyneuropathy,"/>
  <result pre="known to unmask or exacerbate several autoimmune neuromuscular diseases, viz." exact="myasthenia gravis," post="chronic inflammatory demyelinating polyneuropathy, multifocal acquired demyelinating sensory and"/>
  <result pre="unmask or exacerbate several autoimmune neuromuscular diseases, viz. myasthenia gravis," exact="chronic" post="inflammatory demyelinating polyneuropathy, multifocal acquired demyelinating sensory and motor"/>
  <result pre="exacerbate several autoimmune neuromuscular diseases, viz. myasthenia gravis, chronic inflammatory" exact="demyelinating" post="polyneuropathy, multifocal acquired demyelinating sensory and motor neuropathy and"/>
  <result pre="neuromuscular diseases, viz. myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, multifocal" exact="acquired" post="demyelinating sensory and motor neuropathy and some degenerative disorders"/>
  <result pre="diseases, viz. myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, multifocal acquired" exact="demyelinating" post="sensory and motor neuropathy and some degenerative disorders like"/>
  <result pre="chronic inflammatory demyelinating polyneuropathy, multifocal acquired demyelinating sensory and motor" exact="neuropathy" post="and some degenerative disorders like amyotrophic lateral sclerosis and"/>
  <result pre="demyelinating sensory and motor neuropathy and some degenerative disorders like" exact="amyotrophic lateral sclerosis" post="and spinal muscular atrophy. Patients with mitochondrial and metabolic"/>
  <result pre="sensory and motor neuropathy and some degenerative disorders like amyotrophic" exact="lateral sclerosis" post="and spinal muscular atrophy. Patients with mitochondrial and metabolic"/>
  <result pre="neuropathy and some degenerative disorders like amyotrophic lateral sclerosis and" exact="spinal muscular atrophy." post="Patients with mitochondrial and metabolic myopathies are at an"/>
  <result pre="and some degenerative disorders like amyotrophic lateral sclerosis and spinal" exact="muscular atrophy." post="Patients with mitochondrial and metabolic myopathies are at an"/>
  <result pre="mitochondrial and metabolic myopathies are at an increased risk of" exact="rhabdomyolysis" post="with fever and infection. The magnitude of these risks"/>
  <result pre="among these patients, which may increase the chance of acquiring" exact="viral infection." post="IST/IMT may reduce the efficacy of vaccines, which should"/>
  <result pre="is no immediate need to stop these drugs in the" exact="absence of" post="infection. Recommendations regarding the timing of vaccination with the"/>
  <result pre="COVID-19. There was a definite fall in the number of" exact="stroke" post="patients undergoing imaging at a centre in the United"/>
  <result pre="to visit clinics due to transportation restrictions. There is an" exact="acute" post="shortage of hospital beds, ventilators, and most elective workups"/>
  <result pre="shortage of hospital beds, ventilators, and most elective workups for" exact="chronic" post="diseases are being held up. This may adversely affect"/>
  <result pre="common being ARDS. There is evidence that ARDS contributes to" exact="cognitive impairment" post="in several ways â€&quot; damage to the bloodâ€&quot;brain barrier"/>
  <result pre="disease. By and large, it is a disorder involving the" exact="respiratory" post="tract most often. However, growing evidences of extra-pulmonary conditions"/>
  <result pre="the virus on the nervous system and the effects of" exact="systemic" post="illness on the nervous system (hypoxia, sepsis, hypercoagulable states"/>
  <result pre="way in the care of those already living with a" exact="neurological disorder." post="However, a wide spectrum of issues is expected with"/>
  <result pre="communication leading to misadventures. It is of paramount value that" exact="chronic" post="patients continue to get an undisrupted supply of medications"/>
  <result pre="in this present situation, the diciest remains the management of" exact="acute" post="stroke. In the context of COVID-19, the ability to"/>
  <result pre="to infection, and this becomes especially crucial in patients of" exact="acute" post="stroke, given that specific treatment therapies within specified time"/>
  <result pre="and long-term outcome of these patients. Stroke patients may have" exact="symptomatic" post="as well as asymptomatic COVID-19 infection or may develop"/>
  <result pre="Stroke patients may have symptomatic as well as asymptomatic COVID-19" exact="infection" post="or may develop fever during an hospital stay due"/>
  <result pre="or may develop fever during an hospital stay due to" exact="urinary tract infection" post="or aspiration pneumonia as a complication of stroke, thus"/>
  <result pre="develop fever during an hospital stay due to urinary tract" exact="infection" post="or aspiration pneumonia as a complication of stroke, thus"/>
  <result pre="during an hospital stay due to urinary tract infection or" exact="aspiration pneumonia" post="as a complication of stroke, thus necessitating rapid evaluation"/>
  <result pre="an hospital stay due to urinary tract infection or aspiration" exact="pneumonia" post="as a complication of stroke, thus necessitating rapid evaluation"/>
  <result pre="system. Healthcare providers involved in providing care to patients of" exact="acute" post="stroke with COVID-19 infection do have a risk of"/>
  <result pre="Healthcare providers involved in providing care to patients of acute" exact="stroke" post="with COVID-19 infection do have a risk of contracting"/>
  <result pre="in providing care to patients of acute stroke with COVID-19" exact="infection" post="do have a risk of contracting the infection from"/>
  <result pre="with COVID-19 infection do have a risk of contracting the" exact="infection" post="from them, although the exact risk is yet to"/>
  <result pre="circumstances, it therefore becomes essential that recommendations and guidelines on" exact="stroke" post="care be modified as per emergency medical situations, and"/>
  <result pre="neurologists follow what may be aptly termed as a â€œprotected" exact="stroke" post="codeâ€� instead of the regularly practised stroke codes.131â€&quot;135 Recommendations"/>
  <result pre="as a â€œprotected stroke codeâ€� instead of the regularly practised" exact="stroke" post="codes.131â€&quot;135 Recommendations for Managing Stroke During Covid-19131â€&quot;140 First, apart"/>
  <result pre="the use of additional screening protocol, including that of an" exact="infection" post="control screen and a travel history screen for all"/>
  <result pre="based on the recommendations of WHO or CDC.1,141,142 They must" exact="complete" post="screening the patient for infection, assessing for features such"/>
  <result pre="patient for infection, assessing for features such as fever, cough," exact="chest" post="pain, headache, myalgia, shortness of breath and gastrointestinal symptoms"/>
  <result pre="worldwide, travel history becomes less and less important. The protected" exact="stroke" post="code should be activated in any confirmed or suspect"/>
  <result pre="information from the patient or relatives concerned. Approximately 10â€&quot;12% of" exact="stroke" post="patients are known to suffer from cognitive dysfunction, dysarthria,"/>
  <result pre="Approximately 10â€&quot;12% of stroke patients are known to suffer from" exact="cognitive dysfunction," post="dysarthria, aphasia or the absence of near relatives.136,137 Moreover,"/>
  <result pre="stroke patients are known to suffer from cognitive dysfunction, dysarthria," exact="aphasia" post="or the absence of near relatives.136,137 Moreover, acute stroke"/>
  <result pre="known to suffer from cognitive dysfunction, dysarthria, aphasia or the" exact="absence of" post="near relatives.136,137 Moreover, acute stroke patients may also be"/>
  <result pre="dysfunction, dysarthria, aphasia or the absence of near relatives.136,137 Moreover," exact="acute" post="stroke patients may also be in the prodromal phase"/>
  <result pre="dysarthria, aphasia or the absence of near relatives.136,137 Moreover, acute" exact="stroke" post="patients may also be in the prodromal phase of"/>
  <result pre="stroke patients may also be in the prodromal phase of" exact="infection" post="or being asymptomatic carriers. The paramedics should be instructed"/>
  <result pre="should be instructed to activate institutionally and regionally recognised protected" exact="stroke" post="code systems for such patients also and continue with"/>
  <result pre="to be highlighted at this point. Second, once this modified" exact="stroke" post="code is activated, it alerts the stroke care team"/>
  <result pre="once this modified stroke code is activated, it alerts the" exact="stroke" post="care team of the receiving institution. Members of the"/>
  <result pre="stroke care team of the receiving institution. Members of the" exact="stroke" post="team must make certain that basic measures to stop"/>
  <result pre="stroke team must make certain that basic measures to stop" exact="disease" post="transmission are donned at the earliest. This includes wearing"/>
  <result pre="least 2 m) from the patient unless necessary. Given the" exact="acute" post="shortages of personal protective equipment in most regions, the"/>
  <result pre="may be reconsidered based on availability, regional prevalence of SARS-CoV-2" exact="infection" post="and institutional practices. As a routine, full-sleeved gown, extended"/>
  <result pre="below this mask. Third, the number of members on the" exact="stroke" post="team evaluating a patient should be kept as minimum"/>
  <result pre="possible, keeping in mind that those at risk of contracting" exact="infection" post="are best kept back. The fruitful use of tele-stroke"/>
  <result pre="as possible. One bright side is that most aspects of" exact="stroke" post="evaluation can be completed using tele-stroke. Fourth, it is"/>
  <result pre="be assumed for patients with COVID-19 infection. Creation of a" exact="stroke" post="greenway while transporting the patient to consultation suites, imaging"/>
  <result pre="to those who arrive within the correct time windows. Besides" exact="stroke" post="evaluation, the attending healthcare professional should also assess the"/>
  <result pre="but helpful tool in assessing these is the Sequential Organ" exact="Failure" post="Assessment (SOFA) score.143 This is essential because it is"/>
  <result pre="illnesses and multi-organ damage worsen prognosis in COVID-19 patients, and" exact="stroke" post="care needs to be modified accordingly. Both COVID-19 and"/>
  <result pre="stroke care needs to be modified accordingly. Both COVID-19 and" exact="stroke" post="increase the risk of renal insufficiency and adversely affect"/>
  <result pre="modified accordingly. Both COVID-19 and stroke increase the risk of" exact="renal insufficiency" post="and adversely affect their outcome. Before sending a patient"/>
  <result pre="be reasonable to carry out a CT scan of the" exact="chest" post="in conjunction with brain CT. Whenever possible, negative pressure"/>
  <result pre="out a CT scan of the chest in conjunction with" exact="brain" post="CT. Whenever possible, negative pressure isolators should be utilized"/>
  <result pre="shown that the use of rt-PA in patients with ischemic" exact="stroke" post="and higher levels of inflammatory markers has foreseen a"/>
  <result pre="debatable as to whether antiplatelets or anticoagulants are preferred in" exact="acute" post="stroke patients with COVID-19. Due to a lack of"/>
  <result pre="as to whether antiplatelets or anticoagulants are preferred in acute" exact="stroke" post="patients with COVID-19. Due to a lack of any"/>
  <result pre="the people more at a risk of stroke, so that" exact="viral" post="transmission can be nipped off at the bud. Recommendations"/>
  <result pre="at the bud. Recommendations for Care of Patients With Seizure" exact="Disorders" post="There are diverse predicaments faced by those with epilepsy,"/>
  <result pre="them during these trying-and-testing times. Most studies have evinced that" exact="epilepsy" post="does not increase the risk of SARS-CoV-2 infection, lest"/>
  <result pre="has associated comorbidities.145,146 There are however a few exceptions â€&quot;" exact="autoimmune" post="epilepsies, for instance, which make the person more susceptible"/>
  <result pre="epilepsies, for instance, which make the person more susceptible to" exact="infection" post="both due to the disease process itself and as"/>
  <result pre="the person more susceptible to infection both due to the" exact="disease" post="process itself and as an effect of immunomodulatory therapy"/>
  <result pre="and as an effect of immunomodulatory therapy for the underlying" exact="autoimmune" post="process.145,146 It is of paramount importance to communicate to"/>
  <result pre="It is of paramount importance to communicate to patients with" exact="epilepsy" post="the consequences of discontinuation of medication. It is essential"/>
  <result pre="as possible in order to reduce exposure to infection, prevent" exact="acute" post="attacks of seizures/status epilepticus, to minimize visits to the"/>
  <result pre="as part of therapy, and it is irrefutable that severe" exact="infection" post="is often associated with underlying cardiovascular comorbidities. Certain combinations"/>
  <result pre="is irrefutable that severe infection is often associated with underlying" exact="cardiovascular" post="comorbidities. Certain combinations are not recommended, and certain ones"/>
  <result pre="effects and avoidable drug interactions. Furthermore, some drugs used for" exact="symptomatic" post="therapy like antihistamines are capable of lowering seizure thresholds.145"/>
  <result pre="used for symptomatic therapy like antihistamines are capable of lowering" exact="seizure" post="thresholds.145 For certain conditions like Dravet syndrome, where fever"/>
  <result pre="are capable of lowering seizure thresholds.145 For certain conditions like" exact="Dravet syndrome," post="where fever control is crucial to allay seizures, acetaminophen"/>
  <result pre="crucial to allay seizures, acetaminophen can be used.145,146 Patients with" exact="tuberous sclerosis" post="or autoimmune epilepsy syndromes receiving corticosteroids or everolimus, among"/>
  <result pre="seizures, acetaminophen can be used.145,146 Patients with tuberous sclerosis or" exact="autoimmune" post="epilepsy syndromes receiving corticosteroids or everolimus, among others, are"/>
  <result pre="acetaminophen can be used.145,146 Patients with tuberous sclerosis or autoimmune" exact="epilepsy" post="syndromes receiving corticosteroids or everolimus, among others, are potential"/>
  <result pre="to infections.145â€&quot;147 Nevertheless, some studies have shown everolimus to prevent" exact="viral" post="infections.147,148 A major drawback in the treatment of epilepsies"/>
  <result pre="viral infections.147,148 A major drawback in the treatment of epilepsies" exact="and seizures" post="is the limited use of electroencephalography (EEG) and other"/>
  <result pre="infections.147,148 A major drawback in the treatment of epilepsies and" exact="seizures" post="is the limited use of electroencephalography (EEG) and other"/>
  <result pre="drawback in the treatment of epilepsies and seizures is the" exact="limited" post="use of electroencephalography (EEG) and other imaging procedures at"/>
  <result pre="use of video monitoring EEG for the assessment of intractable" exact="seizures" post="can be a useful alternative. Given this extraordinary reduction"/>
  <result pre="treatment (such as weaning off or change in therapies, elective" exact="epilepsy" post="surgeries, etc.) at present unless dictated by exigent reasons."/>
  <result pre="recreational drugs must be reinforced on the patients. Anxiety and" exact="depression" post="are of frequent occurrence in epilepsy patients, which heighten"/>
  <result pre="the patients. Anxiety and depression are of frequent occurrence in" exact="epilepsy" post="patients, which heighten expectedly during periods of stress and"/>
  <result pre="flip side, we have patients suffering from Alzheimerâ€™s disease, Parkinsonâ€™s" exact="disease" post="or other types of dementia and movement disorders, most"/>
  <result pre="suffering from Alzheimerâ€™s disease, Parkinsonâ€™s disease or other types of" exact="dementia" post="and movement disorders, most of whom belong to the"/>
  <result pre="Alzheimerâ€™s disease, Parkinsonâ€™s disease or other types of dementia and" exact="movement disorders," post="most of whom belong to the geriatric population and"/>
  <result pre="to keep a stock of medicines in advance to allay" exact="acute" post="shortages. It is recommended to continue medications for Alzheimerâ€™s"/>
  <result pre="It is recommended to continue medications for Alzheimerâ€™s or Parkinsonâ€™s" exact="disease" post="even in the setting of COVID-19 infection to prevent"/>
  <result pre="Alzheimerâ€™s or Parkinsonâ€™s disease even in the setting of COVID-19" exact="infection" post="to prevent further complications of the underlying illness. The"/>
  <result pre="situations. However, considering the ongoing emergency, elective operations like deep" exact="brain" post="stimulation may be deferred. Recommendations for Patients With Demyelinating"/>
  <result pre="deep brain stimulation may be deferred. Recommendations for Patients With" exact="Demyelinating" post="Disorders152 First, all general measures of personal protection and"/>
  <result pre="infection. Treatment can be restarted after 4 weeks or after" exact="complete" post="resolution of symptoms, keeping in mind the risk of"/>
  <result pre="be continued as well. Drugs with a low risk of" exact="systemic" post="immunosuppression (dimethyl fumarate, teriflunomide) can be safe to start,"/>
  <result pre="(cladribine, alemtuzumab) mandate delaying further courses of treatment based on" exact="disease" post="status, patient factors as well as drug factors. It"/>
  <result pre="always advised to provide individualized treatment based on patient factors," exact="disease" post="status and drug effects. COVID-19 and its Psychological Aftermath"/>
  <result pre="patient factors, disease status and drug effects. COVID-19 and its" exact="Psychological" post="Aftermath As most of us speculate the potential neurological"/>
  <result pre="from Ethiopia showed a threefold increase in the prevalence of" exact="depression" post="in April 2020.141 Surveys across China have reported soaring"/>
  <result pre="April 2020.141 Surveys across China have reported soaring rates of" exact="depression" post="(50%), anxiety (45%) and insomnia (34%) among healthcare personnel.153"/>
  <result pre="Surveys across China have reported soaring rates of depression (50%)," exact="anxiety" post="(45%) and insomnia (34%) among healthcare personnel.153 Similar studies"/>
  <result pre="have reported soaring rates of depression (50%), anxiety (45%) and" exact="insomnia" post="(34%) among healthcare personnel.153 Similar studies from Canada recorded"/>
  <result pre="of psychological support.141 Additionally, at-risk groups include patients contracting the" exact="disease" post="and their relatives, children confined to their homes/quarantine centers"/>
  <result pre="A multitude of factors can be held responsible for such" exact="emotional" post="turmoil being faced by the greater part of the"/>
  <result pre="to see children and young adolescents succumbing to stress and" exact="anxiety" post="in the wake of this adversity.155,156 In view of"/>
  <result pre="adversity.155,156 In view of forestalling further spread of this highly" exact="infectious disease," post="countries around the world have been forced to push"/>
  <result pre="and lack of concentrating abilities among children.155 High incidences of" exact="acute" post="stress disorders, adjustment issues and grief among children isolated"/>
  <result pre="quarantined during a pandemic have been reported.159,160 Parental loss during" exact="childhood" post="does go a long way in the development of"/>
  <result pre="childhood does go a long way in the development of" exact="mood disorders," post="psychosis and increased suicidal rates in the future. There"/>
  <result pre="go a long way in the development of mood disorders," exact="psychosis" post="and increased suicidal rates in the future. There are"/>
  <result pre="the population. In addition to the growing concerns regarding SARS-CoV-2" exact="infection" post="and its precariousness faced by the general population, older"/>
  <result pre="of online and telemedicine is being encouraged. Older adults have" exact="limited" post="access to the internet and smartphones, and consequently most"/>
  <result pre="to benefit from such provisions. Besides, many countries are facing" exact="acute" post="shortages of drugs because of interruption of manufacture, transport"/>
  <result pre="manufacture, transport and business. Likewise, people already living with a" exact="chronic" post="psychiatric problem are unable to access care they would"/>
  <result pre="access care they would normally require to function in a" exact="stable" post="way. Undoubtedly, mental health services have been suppressed to"/>
  <result pre="treatments have been stopped. People already living with an existing" exact="mental illness" post="are more vulnerable to continuous media reporting about the"/>
  <result pre="the cracks and have inflicted on countless others new-found grief," exact="anxiety" post="and depression and inclination towards self-harm. 32% of known"/>
  <result pre="and have inflicted on countless others new-found grief, anxiety and" exact="depression" post="and inclination towards self-harm. 32% of known psychiatric patients"/>
  <result pre="to be addressed are the rising incidences of addiction and" exact="substance abuse." post="Canada has reported an increase in alcohol intake in"/>
  <result pre="group of 15â€&quot;49 years.141 On the other hand, social distancing," exact="limited" post="celebrations and unavailability of addictive substance can lead to"/>
  <result pre="run. On the other end of the spectrum lies the" exact="acute" post="neuropsychiatric problems among those infected with COVID-19 and having"/>
  <result pre="and it is noteworthy that strokes and encephalopathies often have" exact="acute" post="and subacute neuropsychiatric sequelae. Nearly one-third of patients admitted"/>
  <result pre="is noteworthy that strokes and encephalopathies often have acute and" exact="subacute" post="neuropsychiatric sequelae. Nearly one-third of patients admitted in the"/>
  <result pre="organised movements in response to commands. Long-term neuropsychiatric deficits following" exact="acute" post="neurologic disorders are also not uncommon. Salluh etÂ al.161"/>
  <result pre="etÂ al.161 also found persistent neurocognitive deficits in patients with" exact="delirium" post="even after 18 months post discharge. A multitude of"/>
  <result pre="discharge. A multitude of studies have indicated that exposure to" exact="viral" post="infections inÂ utero, childhood or even adulthood placed individuals"/>
  <result pre="A multitude of studies have indicated that exposure to viral" exact="infections" post="inÂ utero, childhood or even adulthood placed individuals at"/>
  <result pre="studies have indicated that exposure to viral infections inÂ utero," exact="childhood" post="or even adulthood placed individuals at an increased risk"/>
  <result pre="or even adulthood placed individuals at an increased risk of" exact="schizophrenia" post="later in life.162,163 Severance etÂ al.164 established an increased"/>
  <result pre="completely shut oneâ€™s eyes to these conceivable problems of SARS-CoV-2" exact="infection" post="in the long run. So how do we terminate"/>
  <result pre="of mental health crisis interventions with the general disposition of" exact="disease" post="prevention and treatment is of indispensable value. Multidisciplinary mental"/>
  <result pre="both patients and healthcare personnel to allay their fears and" exact="anxiety" post="to some extent. Regular screening of suspected patients, confirmed"/>
  <result pre="screening of suspected patients, confirmed cases and health workers for" exact="mental illness" post="should be made a norm rather than exception. On"/>
  <result pre="central health authority of China issued the â€œPrinciples for Emergency" exact="Psychological" post="Crisis Intervention for COVID-19 Pneumonia Epidemicâ€�.165 More than 20"/>
  <result pre="issued the â€œPrinciples for Emergency Psychological Crisis Intervention for COVID-19" exact="Pneumonia" post="Epidemicâ€�.165 More than 20 specific guidelines and expert consensus"/>
  <result pre="will be a fertile breeding ground for an increase in" exact="chronic" post="stress, anxiety, depression, alcohol dependence168 and self-harm. Conclusion Neurological"/>
  <result pre="to more severe pictures such as stroke, seizures, ataxia, polyradiculoneuropathy," exact="encephalopathy" post="and movement disorders. However, it is yet to be"/>
  <result pre="severe pictures such as stroke, seizures, ataxia, polyradiculoneuropathy, encephalopathy and" exact="movement disorders." post="However, it is yet to be established that whether"/>
  <result pre="be better managed as per recommendations available for any particular" exact="disease" post="rather than an individual approach especially amidst pandemic. Finally,"/>
  <result pre="3.GuanW, NiZ, HuY, LiangW, OuC, HeJ. Clinical characteristics of coronavirus" exact="disease" post="2019 in China. N Engl J Med2020;382(18):1708â€&quot;20.32109013 4.MaoL, JinH,"/>
  <result pre="JinH, WangM, et al.Neurologic manifestations of hospitalized patients with coronavirus" exact="disease" post="2019 in Wuhan, China. JAMA Neurol.2020;77(6):1â€&quot;9. 5.JarttiT, JarttiL, RuuskanenO,"/>
  <result pre="2019 in Wuhan, China. JAMA Neurol.2020;77(6):1â€&quot;9. 5.JarttiT, JarttiL, RuuskanenO, SÃ¶derlund-VenermoM.New" exact="respiratory" post="viral infections. Curr Opin Pulmonary Med.2012;18(3):271â€&quot;8.22366993 6.IsonM, HaydenF.Viral infections"/>
  <result pre="in Wuhan, China. JAMA Neurol.2020;77(6):1â€&quot;9. 5.JarttiT, JarttiL, RuuskanenO, SÃ¶derlund-VenermoM.New respiratory" exact="viral" post="infections. Curr Opin Pulmonary Med.2012;18(3):271â€&quot;8.22366993 6.IsonM, HaydenF.Viral infections in"/>
  <result pre="Neurol.2020;77(6):1â€&quot;9. 5.JarttiT, JarttiL, RuuskanenO, SÃ¶derlund-VenermoM.New respiratory viral infections. Curr Opin" exact="Pulmonary" post="Med.2012;18(3):271â€&quot;8.22366993 6.IsonM, HaydenF.Viral infections in immunocompromised patients: whatâ€™s new"/>
  <result pre="SÃ¶derlund-VenermoM.New respiratory viral infections. Curr Opin Pulmonary Med.2012;18(3):271â€&quot;8.22366993 6.IsonM, HaydenF.Viral" exact="infections" post="in immunocompromised patients: whatâ€™s new with respiratory viruses?Curr. Opin"/>
  <result pre="Med.2012;18(3):271â€&quot;8.22366993 6.IsonM, HaydenF.Viral infections in immunocompromised patients: whatâ€™s new with" exact="respiratory" post="viruses?Curr. Opin Infect Dis.2002;15(4):355â€&quot;67.12130931 7.CesarioT.Viruses associated with pneumonia in"/>
  <result pre="new with respiratory viruses?Curr. Opin Infect Dis.2002;15(4):355â€&quot;67.12130931 7.CesarioT.Viruses associated with" exact="pneumonia" post="in adults. Clin Infect Dis.2012;55(1):107â€&quot;13.22423119 8.SlootsT, WhileyD, LambertS, NissenM.Emerging"/>
  <result pre="pneumonia in adults. Clin Infect Dis.2012;55(1):107â€&quot;13.22423119 8.SlootsT, WhileyD, LambertS, NissenM.Emerging" exact="respiratory" post="agents: new viruses for old diseases?J Clin Virol2008;42(3):233â€&quot;43.18406664 9.VareilleM,"/>
  <result pre="KieningerE, EdwardsM, RegameyN.The airway epithelium: soldier in the fight against" exact="respiratory" post="viruses. Clin Microbiol Rev.2011;24(1):210â€&quot;29.21233513 10.McGavernD, KangS.Illuminating viral infections in"/>
  <result pre="the fight against respiratory viruses. Clin Microbiol Rev.2011;24(1):210â€&quot;29.21233513 10.McGavernD, KangS.Illuminating" exact="viral" post="infections in the nervous system. Nat Rev Immunol.2011;11(5):318â€&quot;29.21508982 11.GiraudonP,"/>
  <result pre="fight against respiratory viruses. Clin Microbiol Rev.2011;24(1):210â€&quot;29.21233513 10.McGavernD, KangS.Illuminating viral" exact="infections" post="in the nervous system. Nat Rev Immunol.2011;11(5):318â€&quot;29.21508982 11.GiraudonP, BernardA.Inflammation"/>
  <result pre="moon neurovirology: the merits of studying rare CNS diseases of" exact="viral" post="origin. J Neuroimmune Pharmacol2010;5(3):443â€&quot;55.20419352 14.WangG, LiW, LiK.Acute encephalopathy and"/>
  <result pre="diseases of viral origin. J Neuroimmune Pharmacol2010;5(3):443â€&quot;55.20419352 14.WangG, LiW, LiK.Acute" exact="encephalopathy" post="and encephalitis caused by influenza virus infection. Curr Opin"/>
  <result pre="viral origin. J Neuroimmune Pharmacol2010;5(3):443â€&quot;55.20419352 14.WangG, LiW, LiK.Acute encephalopathy and" exact="encephalitis" post="caused by influenza virus infection. Curr Opin Neurol.2010;23(3):305â€&quot;11.20455276 15.TooveyS.Influenza-Associated"/>
  <result pre="Pharmacol2010;5(3):443â€&quot;55.20419352 14.WangG, LiW, LiK.Acute encephalopathy and encephalitis caused by influenza" exact="virus infection." post="Curr Opin Neurol.2010;23(3):305â€&quot;11.20455276 15.TooveyS.Influenza-Associated central nervous system dysfunction: a"/>
  <result pre="encephalitis caused by influenza virus infection. Curr Opin Neurol.2010;23(3):305â€&quot;11.20455276 15.TooveyS.Influenza-Associated" exact="central nervous system" post="dysfunction: a literature review. Travel Med Infect Dis2008;6(3):114â€&quot;24.18486065 16.EscaffreO,"/>
  <result pre="Travel Med Infect Dis2008;6(3):114â€&quot;24.18486065 16.EscaffreO, BorisevichV, RockxB.Pathogenesis of Hendra and" exact="Nipah virus infection" post="in humans. J Infect Dev Countr2013;7(04):308â€&quot;11. 17.DrexlerJ, Gloza-RauschF, GlendeJ,"/>
  <result pre="Med Infect Dis2008;6(3):114â€&quot;24.18486065 16.EscaffreO, BorisevichV, RockxB.Pathogenesis of Hendra and Nipah" exact="virus infection" post="in humans. J Infect Dev Countr2013;7(04):308â€&quot;11. 17.DrexlerJ, Gloza-RauschF, GlendeJ,"/>
  <result pre="Infect Dis2008;6(3):114â€&quot;24.18486065 16.EscaffreO, BorisevichV, RockxB.Pathogenesis of Hendra and Nipah virus" exact="infection" post="in humans. J Infect Dev Countr2013;7(04):308â€&quot;11. 17.DrexlerJ, Gloza-RauschF, GlendeJ,"/>
  <result pre="Countr2013;7(04):308â€&quot;11. 17.DrexlerJ, Gloza-RauschF, GlendeJ, CormanV, MuthD. Genomic characterization of severe" exact="acute" post="respiratory syndrome-related coronavirus in European bats and classification of"/>
  <result pre="17.DrexlerJ, Gloza-RauschF, GlendeJ, CormanV, MuthD. Genomic characterization of severe acute" exact="respiratory" post="syndrome-related coronavirus in European bats and classification of coronaviruses"/>
  <result pre="coronavirus in European bats and classification of coronaviruses based on" exact="partial" post="RNA-Dependent RNA polymerase gene sequences. J Virol2010;84(21):11336â€&quot;49.20686038 18.De GrootRJ,"/>
  <result pre="View, CA, USA; 2008. 19.CavanaghD.Coronaviruses in poultry and other birds." exact="Avian" post="Pathol.2005;34(6):439â€&quot;48.16537157 20.TalbotPJ, DesforgesM, BrisonE, JacomyH, TkachevS.Coronaviruses as encephalitis-inducing infectious"/>
  <result pre="birds. Avian Pathol.2005;34(6):439â€&quot;48.16537157 20.TalbotPJ, DesforgesM, BrisonE, JacomyH, TkachevS.Coronaviruses as encephalitis-inducing" exact="infectious" post="agents. non-flavirus encephalitis. In-Tech2011;16:185â€&quot;202. 21.DesforgesM, Le CoupanecA, BrisonÃ‰, Meessen-PinardM,"/>
  <result pre="non-flavirus encephalitis. In-Tech2011;16:185â€&quot;202. 21.DesforgesM, Le CoupanecA, BrisonÃ‰, Meessen-PinardM, TalbotPJ. Human" exact="respiratory" post="coronaviruses: neuroinvasive, neurotropic and potentially neurovirulent pathogens. Virologie (Montrouge)2014;18(1):5â€&quot;16.32260043"/>
  <result pre="and immunity In: PerlmanS, GallagherT, SnijderEJ, editors. Nidoviruses. Washington, DC:" exact="American" post="Society of Microbiology Press; 2008 pp. 279â€&quot;98. 23.FoleyJ, LapointeJ,"/>
  <result pre="23.FoleyJ, LapointeJ, KoblikP, PolandA, PedersenN.Diagnostic features of clinical neurologic feline" exact="infectious" post="peritonitis. J Vet Internal Med1998;12(6):415â€&quot;23.9857333 24.KlineKL, JosephRJ, AverillDR, Jr.Feline"/>
  <result pre="infectious peritonitis. J Vet Internal Med1998;12(6):415â€&quot;23.9857333 24.KlineKL, JosephRJ, AverillDR, Jr.Feline" exact="infectious" post="peritonitis with neurologic involvement: clinical and pathological findings in"/>
  <result pre="peritonitis. J Vet Internal Med1998;12(6):415â€&quot;23.9857333 24.KlineKL, JosephRJ, AverillDR, Jr.Feline infectious" exact="peritonitis" post="with neurologic involvement: clinical and pathological findings in 24"/>
  <result pre="24 cats. J Am Animal Hosp Assoc1994;30(2):111â€&quot;8. 25.SlausonDO, FinnJP.Meningoencephalitis and" exact="panophthalmitis" post="in feline infectious peritonitis. J Am Vet Med Assoc1972;160(5):729â€&quot;34.5010614"/>
  <result pre="Am Animal Hosp Assoc1994;30(2):111â€&quot;8. 25.SlausonDO, FinnJP.Meningoencephalitis and panophthalmitis in feline" exact="infectious" post="peritonitis. J Am Vet Med Assoc1972;160(5):729â€&quot;34.5010614 26.LegendreAM, WhitenackDL.Feline infectious"/>
  <result pre="feline infectious peritonitis. J Am Vet Med Assoc1972;160(5):729â€&quot;34.5010614 26.LegendreAM, WhitenackDL.Feline" exact="infectious" post="peritonitis with spinal cord involvement in two cats. J"/>
  <result pre="infectious peritonitis. J Am Vet Med Assoc1972;160(5):729â€&quot;34.5010614 26.LegendreAM, WhitenackDL.Feline infectious" exact="peritonitis" post="with spinal cord involvement in two cats. J Am"/>
  <result pre="Am Vet Med Assoc1975;167(10):31â€&quot;2.52646 27.ArbourN, DayR, NewcombeJ, TalbotP.Neuroinvasion by human" exact="respiratory" post="coronaviruses. J Virol2000;74(19):8913â€&quot;21.10982334 28.ArbourN, CÃ´tÃ©G, LachanceC, TardieuM, CashmanN, TalbotP.Acute"/>
  <result pre="J Virol2000;74(19):8913â€&quot;21.10982334 28.ArbourN, CÃ´tÃ©G, LachanceC, TardieuM, CashmanN, TalbotP.Acute and persistent" exact="infection" post="of human neural cell lines by human coronavirus OC43."/>
  <result pre="J Virol1999;73(4):3338â€&quot;50.10074188 29.ArbourN, EkandÃ©S, CÃ´tÃ©G, LachanceC, ChagnonF, M t. persistent" exact="infection" post="of human oligodendrocytic and neuroglial cell lines by human"/>
  <result pre="human coronavirus 229e. J Virol1999;73(4):3326â€&quot;37.10074187 30.BonaviaA, ArbourN, YongV, TalbotP.Infection of" exact="primary" post="cultures of human neural cells by human coronaviruses 229e"/>
  <result pre="31.XuJ, ZhongS, LiuJ, LiL, LiY, X w. detection of severe" exact="acute" post="respiratory syndrome coronavirus in the brain: potential role of"/>
  <result pre="ZhongS, LiuJ, LiL, LiY, X w. detection of severe acute" exact="respiratory" post="syndrome coronavirus in the brain: potential role of the"/>
  <result pre="LiuJ, LiL, LiY, X w. detection of severe acute respiratory" exact="syndrome" post="coronavirus in the brain: potential role of the chemokine"/>
  <result pre="pathogenesis. Clin Infect Dis.2005;41(8):1089â€&quot;96.16163626 32.GuJ, GongE, ZhangB, et al.Multiple organ" exact="infection" post="and the pathogenesis of SARS. J Exp Med.2005;202(3):415â€&quot;24.16043521 33.DesforgesM,"/>
  <result pre="Exp Med.2005;202(3):415â€&quot;24.16043521 33.DesforgesM, MilettiT, GagnonM, TalbotP.Activation of human monocytes after" exact="infection" post="by human coronavirus 229e. virus research. Virus Res.2007;130(1â€&quot;2):228â€&quot;40.17669539 34.CollinsA.In"/>
  <result pre="from fatal cases of SARS. PLoS Med.2006;3(2):e27.16379499 37.SpiegelM.Interaction of severe" exact="acute" post="respiratory syndrome-associated coronavirus with dendritic cells. J Gen Virol2006;87(7):1953â€&quot;60.16760397"/>
  <result pre="fatal cases of SARS. PLoS Med.2006;3(2):e27.16379499 37.SpiegelM.Interaction of severe acute" exact="respiratory" post="syndrome-associated coronavirus with dendritic cells. J Gen Virol2006;87(7):1953â€&quot;60.16760397 38.BerthSH,"/>
  <result pre="coronavirus with dendritic cells. J Gen Virol2006;87(7):1953â€&quot;60.16760397 38.BerthSH, LeopoldPL, MorfiniGN.Virus-induced" exact="neuronal" post="dysfunction and degeneration. Front Biosci2009;14:5239â€&quot;59. 39.GuoYR, CaoQD, HongZS, et"/>
  <result pre="HongZS, et al.The origin, transmission and clinical therapies on coronavirus" exact="disease" post="2019 (COVID-19) outbreak â€&quot; an update on the status."/>
  <result pre="YiQ, FanS, et al.Relationships among lymphocyte subsets, cytokines, and the" exact="pulmonary" post="inflammation index in coronavirus (COVID-19) infected patients. Br J"/>
  <result pre="Chem Neurosci2020;11(7):995â€&quot;8.32167747 42.WuY, XuX, ChenZ, et al.Nervous system involvement after" exact="infection" post="with COVID-19 and other coronaviruses. Brain Behav Immun.2020;87:18â€&quot;22.32240762 43.VerdecchiaP,"/>
  <result pre="al.Nervous system involvement after infection with COVID-19 and other coronaviruses." exact="Brain" post="Behav Immun.2020;87:18â€&quot;22.32240762 43.VerdecchiaP, CavalliniC, SpanevelloA, AngeliF.The pivotal link between"/>
  <result pre="Behav Immun.2020;87:18â€&quot;22.32240762 43.VerdecchiaP, CavalliniC, SpanevelloA, AngeliF.The pivotal link between ACE2" exact="deficiency" post="and SARS-CoV-2 infection. Eur J Intern Med.2020;76:14â€&quot;20.32336612 44.VargaZ, FlammerAJ,"/>
  <result pre="Eur J Intern Med.2020;76:14â€&quot;20.32336612 44.VargaZ, FlammerAJ, SteigerP, et al.Endothelial cell" exact="infection" post="and endotheliitis in COVID-19. Lancet.2020;395(10234):1417â€&quot;8.32325026 45.TsaiLK, HsiehST, ChangYC.Neurological manifestations"/>
  <result pre="endotheliitis in COVID-19. Lancet.2020;395(10234):1417â€&quot;8.32325026 45.TsaiLK, HsiehST, ChangYC.Neurological manifestations in severe" exact="acute" post="respiratory syndrome. Acta Neurolog Taiwan.2005;14(3):113â€&quot;9. 46.StainsbyB, HowittS, PorrJ.Neuromusculoskeletal disorders"/>
  <result pre="in COVID-19. Lancet.2020;395(10234):1417â€&quot;8.32325026 45.TsaiLK, HsiehST, ChangYC.Neurological manifestations in severe acute" exact="respiratory" post="syndrome. Acta Neurolog Taiwan.2005;14(3):113â€&quot;9. 46.StainsbyB, HowittS, PorrJ.Neuromusculoskeletal disorders following"/>
  <result pre="RNA in the cerebrospinal fluid of a patient with severe" exact="acute" post="respiratory syndrome. Clin Chem2003; 49(12):2108â€&quot;9.14633896 50.YehEA, CollinsA, CohenME, DuffnerPK,"/>
  <result pre="in the cerebrospinal fluid of a patient with severe acute" exact="respiratory" post="syndrome. Clin Chem2003; 49(12):2108â€&quot;9.14633896 50.YehEA, CollinsA, CohenME, DuffnerPK, FadenH.Detection"/>
  <result pre="49(12):2108â€&quot;9.14633896 50.YehEA, CollinsA, CohenME, DuffnerPK, FadenH.Detection of coronavirus in the" exact="central nervous system" post="of a child with acute disseminated encephalomyelitis. Pediatrics.2004; 113(1):e73â€&quot;6.14702500"/>
  <result pre="coronavirus in the central nervous system of a child with" exact="acute" post="disseminated encephalomyelitis. Pediatrics.2004; 113(1):e73â€&quot;6.14702500 51.LauKK, YuWC, ChuCM, LauST, ShengB,"/>
  <result pre="disseminated encephalomyelitis. Pediatrics.2004; 113(1):e73â€&quot;6.14702500 51.LauKK, YuWC, ChuCM, LauST, ShengB, YuenKY.Possible" exact="central nervous system" post="infection by SARS coronavirus. Emerg Infect Dis.2004;10(2):342â€&quot;4.15030709 52.KimJE, HeoJH,"/>
  <result pre="113(1):e73â€&quot;6.14702500 51.LauKK, YuWC, ChuCM, LauST, ShengB, YuenKY.Possible central nervous system" exact="infection" post="by SARS coronavirus. Emerg Infect Dis.2004;10(2):342â€&quot;4.15030709 52.KimJE, HeoJH, KimHO,"/>
  <result pre="HeoJH, KimHO, et al.Neurological complications during treatment of Middle East" exact="respiratory" post="syndrome. J Clin Neurol2017;13(3):227â€&quot;33.28748673 53.SaadM, OmraniA, BaigK, BahloulA, ElzeinF."/>
  <result pre="Clinical aspects and outcomes of 70 patients with Middle East" exact="respiratory" post="syndrome coronavirus infection: a single-center experience in Saudi Arabia."/>
  <result pre="aspects and outcomes of 70 patients with Middle East respiratory" exact="syndrome" post="coronavirus infection: a single-center experience in Saudi Arabia. Int"/>
  <result pre="Arabia. Int J Infect Dis.2014;29:301â€&quot;6.25303830 54.LiY, WangM, ZhouY, et al.Acute" exact="cerebrovascular disease" post="following COVID-19: a single center, retrospective, observational study. Stroke"/>
  <result pre="Int J Infect Dis.2014;29:301â€&quot;6.25303830 54.LiY, WangM, ZhouY, et al.Acute cerebrovascular" exact="disease" post="following COVID-19: a single center, retrospective, observational study. Stroke"/>
  <result pre="(SARS-CoV-2) pandemic 2019â€&quot;2020. J Neurol Neurosurg Psychiatry2020;91(6):669â€&quot;70.32312873 57.SedaghatZ, KarimiN.Guillain Barre" exact="syndrome" post="associated with COVID-19 infection: a case report. J Clin"/>
  <result pre="case report. J Clin Neurosci2020;76:233â€&quot;5.32312628 58.ZhaoH, ShenD, ZhouH, LiuJ, ChenS.Guillain-BarrÃ©" exact="syndrome" post="associated with SARS-CoV-2 infection: causality or coincidence?Lancet Neurol.2020;19(5):383â€&quot;4.32246917 59.ChenN,"/>
  <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet2020;395(10223):507â€&quot;13.32007143 60.WangD, HuB,"/>
  <result pre="Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirusâ€&quot;infected" exact="pneumonia" post="in Wuhan, China. JAMA.2020;323(11):1061â€&quot;9.32031570 61.OxleyTJ, MoccoJ, MajidiS, et al.Large-vessel"/>
  <result pre="pneumonia in Wuhan, China. JAMA.2020;323(11):1061â€&quot;9.32031570 61.OxleyTJ, MoccoJ, MajidiS, et al.Large-vessel" exact="stroke" post="as a presenting feature of Covid-19 in the young."/>
  <result pre="et al.Self-reported olfactory and taste disorders in patients with severe" exact="acute" post="respiratory coronavirus 2 infection: a cross-sectional study. Clin Infect"/>
  <result pre="al.Self-reported olfactory and taste disorders in patients with severe acute" exact="respiratory" post="coronavirus 2 infection: a cross-sectional study. Clin Infect Dis.2020:ciaa330."/>
  <result pre="et al.High expression of ACE2 receptor of 2019-nCoV on the" exact="epithelial" post="cells of oral mucosa. Int J Oral Sci2020;12(1):1â€&quot;5.31900382 71.GhoshR,"/>
  <result pre="72.UmapathiT, KorA, VenketasubramanianN, LimC, PangB, T Y. Large artery ischaemic" exact="stroke" post="in severe acute respiratory syndrome (SARS). J Neurol2004;251(10):1227â€&quot;31.15503102 73.ArabiYM,"/>
  <result pre="LimC, PangB, T Y. Large artery ischaemic stroke in severe" exact="acute" post="respiratory syndrome (SARS). J Neurol2004;251(10):1227â€&quot;31.15503102 73.ArabiYM, HarthiA, HusseinJ, et"/>
  <result pre="PangB, T Y. Large artery ischaemic stroke in severe acute" exact="respiratory" post="syndrome (SARS). J Neurol2004;251(10):1227â€&quot;31.15503102 73.ArabiYM, HarthiA, HusseinJ, et al.Severe"/>
  <result pre="T Y. Large artery ischaemic stroke in severe acute respiratory" exact="syndrome" post="(SARS). J Neurol2004;251(10):1227â€&quot;31.15503102 73.ArabiYM, HarthiA, HusseinJ, et al.Severe neurologic"/>
  <result pre="syndrome (SARS). J Neurol2004;251(10):1227â€&quot;31.15503102 73.ArabiYM, HarthiA, HusseinJ, et al.Severe neurologic" exact="syndrome" post="associated with Middle East respiratory syndrome corona virus (MERS-CoV)."/>
  <result pre="HarthiA, HusseinJ, et al.Severe neurologic syndrome associated with Middle East" exact="respiratory" post="syndrome corona virus (MERS-CoV). Infection.2015;43(4):495â€&quot;501.25600929 74.ChenCY, LeeCH, LiuCY, WangJH,"/>
  <result pre="HusseinJ, et al.Severe neurologic syndrome associated with Middle East respiratory" exact="syndrome" post="corona virus (MERS-CoV). Infection.2015;43(4):495â€&quot;501.25600929 74.ChenCY, LeeCH, LiuCY, WangJH, WangLM,"/>
  <result pre="LeeCH, LiuCY, WangJH, WangLM, PerngRP.Clinical features and outcomes of severe" exact="acute" post="respiratory syndrome and predictive factors for acute respiratory distress"/>
  <result pre="LiuCY, WangJH, WangLM, PerngRP.Clinical features and outcomes of severe acute" exact="respiratory" post="syndrome and predictive factors for acute respiratory distress syndrome."/>
  <result pre="WangJH, WangLM, PerngRP.Clinical features and outcomes of severe acute respiratory" exact="syndrome" post="and predictive factors for acute respiratory distress syndrome. J"/>
  <result pre="outcomes of severe acute respiratory syndrome and predictive factors for" exact="acute" post="respiratory distress syndrome. J Chin Med Assoc2005;68(1):4â€&quot;10.15742856 75.ChanJW, NgCK,"/>
  <result pre="of severe acute respiratory syndrome and predictive factors for acute" exact="respiratory" post="distress syndrome. J Chin Med Assoc2005;68(1):4â€&quot;10.15742856 75.ChanJW, NgCK, ChanYH,"/>
  <result pre="risk factors for adverse clinical outcomes in adults with severe" exact="acute" post="respiratory syndrome (SARS). Thorax.2003;58(8):686â€&quot;9.12885985 76.QinC, ZhouL, HuZ, et al.Dysregulation"/>
  <result pre="factors for adverse clinical outcomes in adults with severe acute" exact="respiratory" post="syndrome (SARS). Thorax.2003;58(8):686â€&quot;9.12885985 76.QinC, ZhouL, HuZ, et al.Dysregulation of"/>
  <result pre="for adverse clinical outcomes in adults with severe acute respiratory" exact="syndrome" post="(SARS). Thorax.2003;58(8):686â€&quot;9.12885985 76.QinC, ZhouL, HuZ, et al.Dysregulation of immune"/>
  <result pre="al.Clinical course and outcomes of critically ill patients with SARS-CoV-2" exact="pneumonia" post="in Wuhan, China: a single-centered, retrospective, observational study. Lancet"/>
  <result pre="relation to COVID-19 in Italy. JAMA.2020;323(18):1775â€&quot;6.32203977 82.AggarwalG, LippiG, Michael HenryB.Cerebrovascular" exact="disease" post="is associated with an increased disease severity in patients"/>
  <result pre="82.AggarwalG, LippiG, Michael HenryB.Cerebrovascular disease is associated with an increased" exact="disease" post="severity in patients with Coronavirus Disease 2019 (COVID-19): a"/>
  <result pre="associated with an increased disease severity in patients with Coronavirus" exact="Disease" post="2019 (COVID-19): a pooled analysis of published literature. Int"/>
  <result pre="J Stroke2020;15(4):385â€&quot;9.32310015 83.AvulaA, NalleballeK, NarulaN, et al.COVID-19 presenting as stroke." exact="Brain" post="Behav Immun2020;87:115â€&quot;9.32360439 84.GrauAJ, BuggleF, HeindlS, et al.Recent infection as"/>
  <result pre="as stroke. Brain Behav Immun2020;87:115â€&quot;9.32360439 84.GrauAJ, BuggleF, HeindlS, et al.Recent" exact="infection" post="as a risk factor for cerebrovascular ischemia. Stroke1995;26(3):373â€&quot;9.7886709 85.BenussiA,"/>
  <result pre="BuggleF, HeindlS, et al.Recent infection as a risk factor for" exact="cerebrovascular ischemia." post="Stroke1995;26(3):373â€&quot;9.7886709 85.BenussiA, PilottoA, PremiE, et al.Clinical characteristics and outcomes"/>
  <result pre="PilottoA, PremiE, et al.Clinical characteristics and outcomes of inpatients with" exact="neurologic disease" post="and COVID-19 in Brescia, Lombardy, Italy. Neurology2020;10.1212/WNL.0000000000009848. 86.KlokFA, KruipMJ,"/>
  <result pre="PremiE, et al.Clinical characteristics and outcomes of inpatients with neurologic" exact="disease" post="and COVID-19 in Brescia, Lombardy, Italy. Neurology2020;10.1212/WNL.0000000000009848. 86.KlokFA, KruipMJ,"/>
  <result pre="analysis. Thromb Res.2020;191:148â€&quot;50.32381264 87.HelmsJ, TacquardC, SeveracF, et al.High risk of" exact="thrombosis" post="in patients with severe SARS-CoV-2 infection: a multicenter prospective"/>
  <result pre="associated with SARS-Coronavirus-2. Int J Infect Dis.2020;94:55â€&quot;8.32251791 91.YeM, RenY, LvT." exact="Encephalitis" post="as a clinical manifestation of COVID-19. 2020;S0889â€&quot;1591(20)30465â€&quot;7. 92.FilatovA, SharmaP,"/>
  <result pre="of COVID-19. 2020;S0889â€&quot;1591(20)30465â€&quot;7. 92.FilatovA, SharmaP, HindiF, EspinosaPS.Neurological complications of coronavirus" exact="disease" post="(COVID-19): encephalopathy. Cureus.2020;12(3):e7352.32328364 93.PoyiadjiN, ShahinG, NoujaimD, StoneM, PatelS, GriffithB.COVID-19-associated"/>
  <result pre="disease (COVID-19): encephalopathy. Cureus.2020;12(3):e7352.32328364 93.PoyiadjiN, ShahinG, NoujaimD, StoneM, PatelS, GriffithB.COVID-19-associated" exact="acute" post="hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology2020;201187. 94.HuangYH,"/>
  <result pre="MRI features. Radiology2020;201187. 94.HuangYH, JiangD, HuangJT.A case of COVID-19 encephalitis." exact="Brain" post="Behav Immun.2020;87:149.32387508 95.McAbeeGN, BrosgolY, PavlakisS, AghaR, GaffoorM.Encephalitis associated with"/>
  <result pre="Behav Immun.2020;87:149.32387508 95.McAbeeGN, BrosgolY, PavlakisS, AghaR, GaffoorM.Encephalitis associated with COVID-19" exact="infection" post="in an 11 year-old child. Pediatr Neurol.2020;S0887â€&quot;8994(20)30143â€&quot;0. 96.DuongL, XuP,"/>
  <result pre="an 11 year-old child. Pediatr Neurol.2020;S0887â€&quot;8994(20)30143â€&quot;0. 96.DuongL, XuP, LiuA.Meningoencephalitis without" exact="respiratory" post="failure in a young female patient with COVID-19 infection"/>
  <result pre="Neurol.2020;S0887â€&quot;8994(20)30143â€&quot;0. 96.DuongL, XuP, LiuA.Meningoencephalitis without respiratory failure in a young" exact="female" post="patient with COVID-19 infection in downtown Los Angeles, early"/>
  <result pre="without respiratory failure in a young female patient with COVID-19" exact="infection" post="in downtown Los Angeles, early April 2020. Brain Behav"/>
  <result pre="with COVID-19 infection in downtown Los Angeles, early April 2020." exact="Brain" post="Behav Immun.2020;17:S0889â€&quot;1591(20)30509â€&quot;2. 97.XiangP, XuXM, GaoLL, WangHZ, XiongHF, LiRH.First case"/>
  <result pre="XuXM, GaoLL, WangHZ, XiongHF, LiRH.First case of 2019 novel coronavirus" exact="disease" post="with encephalitis. ChinaXiv2020;202003:00015. 98.BiQ, WuY, MeiS, et al.Epidemiology and"/>
  <result pre="close contacts. MedRxiv. 2020. 99.VirhammarJ, KumlienE, FÃ¤llmarD, et al.Acute necrotizing" exact="encephalopathy" post="with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology.2020; doi:"/>
  <result pre="cerebrospinal fluid. Neurology.2020; doi: 10.1212/WNL.0000000000010250 100.LuL, XiongW, LiuD, et al.New-onset" exact="acute" post="symptomatic seizure and risk factors in Corona virus disease"/>
  <result pre="fluid. Neurology.2020; doi: 10.1212/WNL.0000000000010250 100.LuL, XiongW, LiuD, et al.New-onset acute" exact="symptomatic" post="seizure and risk factors in Corona virus disease 2019:"/>
  <result pre="Neurology.2020; doi: 10.1212/WNL.0000000000010250 100.LuL, XiongW, LiuD, et al.New-onset acute symptomatic" exact="seizure" post="and risk factors in Corona virus disease 2019: a"/>
  <result pre="al.New-onset acute symptomatic seizure and risk factors in Corona virus" exact="disease" post="2019: a retrospective multicenter study. Epilepsia2020;61(6):e49â€&quot;e53.32304092 101.DugueR, Cay-MartÃ­nezKC, ThakurK,"/>
  <result pre="an infant with COVID-19. Neurology2020;94(24):1100â€&quot;2.32327489 102.VollonoC, RolloE, RomozziM, et al.Focal" exact="status epilepticus" post="as unique clinical feature of COVID-19: a case report."/>
  <result pre="CornfordME.Sudden unexpected death associated with HHV-6 in an adolescent with" exact="tuberous sclerosis." post="Pediatr Neurol.1999;21(1):488â€&quot;91.10428436 105.LahiriD, ArdilaA.COVID-19 pandemic: a neurological perspective. Cureus.2020;12(4)."/>
  <result pre="pathological changes of extra-lung organs in a case of severe" exact="acute" post="respiratory syndrome. Med J Chin PLA.2003;28:480â€&quot;1. 107.Xiang-huaY, Le-minW, Ai-binL,"/>
  <result pre="changes of extra-lung organs in a case of severe acute" exact="respiratory" post="syndrome. Med J Chin PLA.2003;28:480â€&quot;1. 107.Xiang-huaY, Le-minW, Ai-binL, et"/>
  <result pre="syndrome. Med J Chin PLA.2003;28:480â€&quot;1. 107.Xiang-huaY, Le-minW, Ai-binL, et al.Severe" exact="acute" post="respiratory syndrome and venous thromboembolism in multiple organs. Am"/>
  <result pre="Med J Chin PLA.2003;28:480â€&quot;1. 107.Xiang-huaY, Le-minW, Ai-binL, et al.Severe acute" exact="respiratory" post="syndrome and venous thromboembolism in multiple organs. Am J"/>
  <result pre="J Chin PLA.2003;28:480â€&quot;1. 107.Xiang-huaY, Le-minW, Ai-binL, et al.Severe acute respiratory" exact="syndrome" post="and venous thromboembolism in multiple organs. Am J Respir"/>
  <result pre="PLA.2003;28:480â€&quot;1. 107.Xiang-huaY, Le-minW, Ai-binL, et al.Severe acute respiratory syndrome and" exact="venous thromboembolism" post="in multiple organs. Am J Respir Crit Care Med.2010;182(3):436â€&quot;7.20675682"/>
  <result pre="Eur J Neurol.2006; 13(2):112â€&quot;24.16490040 110.ZhaoK, HuangJ, DaiD, FengY, LiuL, NieS.Acute" exact="myelitis" post="after SARS-CoV-2 infection: a case report. MedRxiv.2020. 111.JinM, TongQ.Rhabdomyolysis"/>
  <result pre="and neuromuscular disorders. Neurology2020;94(22):959â€&quot;69.32284362 114.WatrinL, GhawchÃ©F, LarreP, NeauJP, MathisS, FournierE.Guillain-BarrÃ©" exact="syndrome" post="(42 cases) occurring during a Zika virus outbreak in"/>
  <result pre="Med. (Baltimore). 2016;95(14):e3257. doi: 10.1097/MD.0000000000003257 115.ToscanoG, PalmeriniF, RavagliaS, et al.Guillain-Barre" exact="syndrome" post="associated with SARS-CoV-2. N Engl J Med.2020;382(26):2574â€&quot;6.32302082 116.ViraniA, RaboldE,"/>
  <result pre="SARS-CoV-2. N Engl J Med.2020;382(26):2574â€&quot;6.32302082 116.ViraniA, RaboldE, HansonT, et al.Guillain-BarrÃ©" exact="syndrome" post="associated with SARS-CoV-2 infection. IDCases.2020;20:e00771.32313807 117.OttavianiD, BosoF, TranquilliniE, et"/>
  <result pre="with SARS-CoV-2 infection. IDCases.2020;20:e00771.32313807 117.OttavianiD, BosoF, TranquilliniE, et al.Early Guillain-BarrÃ©" exact="syndrome" post="in coronavirus disease 2019 (COVID-19): a case report from"/>
  <result pre="IDCases.2020;20:e00771.32313807 117.OttavianiD, BosoF, TranquilliniE, et al.Early Guillain-BarrÃ© syndrome in coronavirus" exact="disease" post="2019 (COVID-19): a case report from an Italian COVID-hospital."/>
  <result pre="an Italian COVID-hospital. Neurol Sci.2020;41(6):1351â€&quot;4.32399950 118.PadroniM, MastrangeloV, AsioliGM, et al.Guillain-BarrÃ©" exact="syndrome" post="following COVID-19: new infection, old complication?J Neurol.2020;267(7):1877â€&quot;9.32333166 119.AlbertiP, BerettaS,"/>
  <result pre="new infection, old complication?J Neurol.2020;267(7):1877â€&quot;9.32333166 119.AlbertiP, BerettaS, PiattiM, et al.Guillain-BarrÃ©" exact="syndrome" post="related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm.2020;7(4):e741.32350026 120.CoenM, JeansonG,"/>
  <result pre="COVID-19 infection. Neurol Neuroimmunol Neuroinflamm.2020;7(4):e741.32350026 120.CoenM, JeansonG, AlmeidaLA, et al.Guillain-BarrÃ©" exact="syndrome" post="as a complication of SARS-CoV-2 infection. Brain Behav Immun.2020;87:111â€&quot;2.32360440"/>
  <result pre="AlmeidaLA, et al.Guillain-BarrÃ© syndrome as a complication of SARS-CoV-2 infection." exact="Brain" post="Behav Immun.2020;87:111â€&quot;2.32360440 121.GutiÃ©rrez-OrtizC, MÃ©ndezA, Rodrigo-ReyS, et al.Miller Fisher syndrome"/>
  <result pre="SARS-CoV-2 infection. Brain Behav Immun.2020;87:111â€&quot;2.32360440 121.GutiÃ©rrez-OrtizC, MÃ©ndezA, Rodrigo-ReyS, et al.Miller" exact="Fisher syndrome" post="and polyneuritis cranialis in COVID-19. Neurology.2020; doi: 10.1212/WNL.0000000000009619. 122.DinkinM,"/>
  <result pre="infection. Brain Behav Immun.2020;87:111â€&quot;2.32360440 121.GutiÃ©rrez-OrtizC, MÃ©ndezA, Rodrigo-ReyS, et al.Miller Fisher" exact="syndrome" post="and polyneuritis cranialis in COVID-19. Neurology.2020; doi: 10.1212/WNL.0000000000009619. 122.DinkinM,"/>
  <result pre="10.1212/WNL.0000000000009619. 122.DinkinM, GaoV, KahanJ, et al.COVID-19 presenting with ophthalmoparesis from" exact="cranial nerve palsy." post="Neurology2020; doi: 10.1212/WNL.0000000000009700. 123.TaamsNE, NotermansNC, FokkinkWJ, et al.Clinical relevance"/>
  <result pre="122.DinkinM, GaoV, KahanJ, et al.COVID-19 presenting with ophthalmoparesis from cranial" exact="nerve" post="palsy. Neurology2020; doi: 10.1212/WNL.0000000000009700. 123.TaamsNE, NotermansNC, FokkinkWJ, et al.Clinical"/>
  <result pre="ChenH, et al.Clinical characteristics of 113 deceased patients with coronavirus" exact="disease" post="2019: retrospective study. BMJ. 2020;368:m1091.32217556 126.HermanC, MayerK, SarwalA.Scoping review"/>
  <result pre="study. Mult Scler Relat Disord.2020;41:101982.32070858 128.BarzegarM, MirmosayyebO, NehzatN, et al.COVID-19" exact="infection" post="in a patient with multiple sclerosis treated with fingolimod."/>
  <result pre="128.BarzegarM, MirmosayyebO, NehzatN, et al.COVID-19 infection in a patient with" exact="multiple sclerosis" post="treated with fingolimod. Neurol Neuroimmunol Neuroinflamm.2020;7(4):e753.32371550 129.KansagraAP, GoyalMS, HamiltonS,"/>
  <result pre="Neuroimmunol Neuroinflamm.2020;7(4):e753.32371550 129.KansagraAP, GoyalMS, HamiltonS, AlbersGW.Collateral effect of Covid-19 on" exact="stroke" post="evaluation in the United States. N Engl J Med."/>
  <result pre="United States. N Engl J Med. 2020;NEJMc2014816. 130.SasannejadC, ElyEW, LahiriS.Long-term" exact="cognitive impairment" post="after acute respiratory distress syndrome: a review of clinical"/>
  <result pre="Engl J Med. 2020;NEJMc2014816. 130.SasannejadC, ElyEW, LahiriS.Long-term cognitive impairment after" exact="acute" post="respiratory distress syndrome: a review of clinical impact and"/>
  <result pre="J Med. 2020;NEJMc2014816. 130.SasannejadC, ElyEW, LahiriS.Long-term cognitive impairment after acute" exact="respiratory" post="distress syndrome: a review of clinical impact and pathophysiological"/>
  <result pre="and pathophysiological mechanisms. Crit Care2019;23(1):352.31718695 131.LeiraEC, RussmanAN, BillerJ, et al.Preserving" exact="stroke" post="care during the COVID-19 pandemic: Potential issues and solutions."/>
  <result pre="doi: 10.1212/WNL.0000000000009713. 132.KhosravaniH, RajendramP, NotarioL, ChapmanMG, MenonBK.Protected code stroke: hyperacute" exact="stroke" post="management during the coronavirus disease 2019. COVID-19. Stroke. 2020;51(6):1891â€&quot;5.32233980"/>
  <result pre="ChapmanMG, MenonBK.Protected code stroke: hyperacute stroke management during the coronavirus" exact="disease" post="2019. COVID-19. Stroke. 2020;51(6):1891â€&quot;5.32233980 133.ZhaoJ, RuddA, LiuR.Challenges and potential"/>
  <result pre="COVID-19. Stroke. 2020;51(6):1891â€&quot;5.32233980 133.ZhaoJ, RuddA, LiuR.Challenges and potential solutions of" exact="stroke" post="care during the coronavirus disease 2019 (COVID-19) outbreak. Stroke.2020;51(5):1356â€&quot;7.32228369"/>
  <result pre="LiuR.Challenges and potential solutions of stroke care during the coronavirus" exact="disease" post="2019 (COVID-19) outbreak. Stroke.2020;51(5):1356â€&quot;7.32228369 134.QureshiAI, Abd-AllahF, AlsenaniF, et al.Management"/>
  <result pre="2019 (COVID-19) outbreak. Stroke.2020;51(5):1356â€&quot;7.32228369 134.QureshiAI, Abd-AllahF, AlsenaniF, et al.Management of" exact="acute" post="ischemic stroke in patients with COVID-19 infection: report of"/>
  <result pre="outbreak. Stroke.2020;51(5):1356â€&quot;7.32228369 134.QureshiAI, Abd-AllahF, AlsenaniF, et al.Management of acute ischemic" exact="stroke" post="in patients with COVID-19 infection: report of an international"/>
  <result pre="Temporary Emergency Guidance to US Stroke Centers During the Coronavirus" exact="Disease" post="2019 (COVID-19) Pandemic: On Behalf of the American Heart"/>
  <result pre="the Coronavirus Disease 2019 (COVID-19) Pandemic: On Behalf of the" exact="American" post="Heart Association/American Stroke Association Stroke Council Leadership. Stroke. 2020;51(6):1910â€&quot;2.32233972"/>
  <result pre="Coronavirus Disease 2019 (COVID-19) Pandemic: On Behalf of the American" exact="Heart" post="Association/American Stroke Association Stroke Council Leadership. Stroke. 2020;51(6):1910â€&quot;2.32233972 136.QureshiAI,"/>
  <result pre="informed consent acquisition in patients undergoing emergent endovascular treatment for" exact="acute" post="ischemic stroke. J Vasc Interv Neurol.2014;7(2):21â€&quot;5. 137.KimDH, SaverJL, StarkmanS,"/>
  <result pre="yield and reasons for screen failure in a large prehospital" exact="stroke" post="trial. Stroke.2016;47(1):232â€&quot;5.26658446 138.TiainenM, MeretojaA, StrbianD, et al.Helsinki Stroke Thrombolysis"/>
  <result pre="StrbianD, et al.Helsinki Stroke Thrombolysis Registry Group. Body temperature, blood" exact="infection" post="parameters, and outcome of thrombolysis-treated ischemic stroke patients. Int"/>
  <result pre="Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic" exact="stroke" post="patients. Int J Stroke2013;8(8):632â€&quot;8.23590464 139.SangalliD, PoloniaV, ColomboD, et al.A"/>
  <result pre="PoloniaV, ColomboD, et al.A single-centre experience of intravenous thrombolysis for" exact="stroke" post="in COVID-19 patients. Neurol Sci.2020;1â€&quot;5. 140.HsuPJ, ChenCH, YehSJ, TsaiLK,"/>
  <result pre="YehSJ, TsaiLK, TangSC, JengJS.High plasma D-dimer indicates unfavorable outcome of" exact="acute" post="ischemic stroke patients receiving intravenous thrombolysis. Cerebrovasc Dis.2016;42(1â€&quot;2):117â€&quot;21.27088493 141.Who.int."/>
  <result pre="TangSC, JengJS.High plasma D-dimer indicates unfavorable outcome of acute ischemic" exact="stroke" post="patients receiving intravenous thrombolysis. Cerebrovasc Dis.2016;42(1â€&quot;2):117â€&quot;21.27088493 141.Who.int. 2020. Available"/>
  <result pre="141.Who.int. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public; accessed May 30, 2020. 142.Coronavirus" exact="Disease" post="2019 (COVID-19) [Internet]. Centers for Disease Control and Prevention."/>
  <result pre="May 30, 2020. 142.Coronavirus Disease 2019 (COVID-19) [Internet]. Centers for" exact="Disease" post="Control and Prevention. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html; accessed May"/>
  <result pre="SeymourCW, et al.The third international consensus definitions for sepsis and" exact="septic shock" post="(Sepsis-3). JAMA2016;315(8):801â€&quot;10.26903338 144.TanswellP, SeifriedE, StangE, KrauseJ.Pharmacokinetics and hepatic catabolism"/>
  <result pre="plasminogen activator. Arzneimittelforschung1991;41(12):1310â€&quot;9.1815534 145.FrenchJA, BrodieMJ, CaraballoR, et al.Keeping people with" exact="epilepsy" post="safe during the Covid-19 pandemic. Neurology2020;94(23):1032â€&quot;7.32327490 146.collab: CDC COVID-19"/>
  <result pre="prevalence of selected underlying health conditions among patients with coronavirus" exact="disease" post="2019â€&quot;United States, February 12â€&quot;March 28, 2020. MMWR Morb Mortal"/>
  <result pre="MMWR Morb Mortal Wkly Rep.2020;69(13):382â€&quot;6.32240123 147.HillJA, HummelM, StarlingRC, et al.A" exact="lower" post="incidence of cytomegalovirus infection in deÂ novo heart transplant"/>
  <result pre="Wkly Rep.2020;69(13):382â€&quot;6.32240123 147.HillJA, HummelM, StarlingRC, et al.A lower incidence of" exact="cytomegalovirus infection" post="in deÂ novo heart transplant recipients randomized to everolimus."/>
  <result pre="Rep.2020;69(13):382â€&quot;6.32240123 147.HillJA, HummelM, StarlingRC, et al.A lower incidence of cytomegalovirus" exact="infection" post="in deÂ novo heart transplant recipients randomized to everolimus."/>
  <result pre="et al.A lower incidence of cytomegalovirus infection in deÂ novo" exact="heart" post="transplant recipients randomized to everolimus. Transplantation2007;84(11):1436â€&quot;42.18091519 148.TanL, SatoN, ShirakiA,"/>
  <result pre="suppressed cytomegalovirus DNA synthesis, spread of the infection, and alleviated" exact="cytomegalovirus infection." post="Antiviral Res.2019;162:30â€&quot;8.30543830 149.WangH, LiT, BarbarinoP, et al.Dementia care during"/>
  <result pre="150.FasanoA, AntoniniA, KatzenschlagerR, et al.Management of advanced therapies in Parkinsonâ€™s" exact="disease" post="patients in times of humanitarian crisis: the COVID-19 experience."/>
  <result pre="patients in times of humanitarian crisis: the COVID-19 experience. Mov" exact="Disorders" post="Clin Practice2020;7(4):361â€&quot;72. 151.PapaSM, BrundinP, FungVS, KangUJ, BurnDJ, ColosimoC, ChiangHL,"/>
  <result pre="MDS-Scientific Issues Committee. Impact of the COVID-19 pandemic on Parkinsonâ€™s" exact="disease" post="and movement disorders. Mov Disord.2020;35(5):711â€&quot;5.32250460 152.BrownleeW, BourdetteD, BroadleyS, KillesteinJ,"/>
  <result pre="Committee. Impact of the COVID-19 pandemic on Parkinsonâ€™s disease and" exact="movement disorders." post="Mov Disord.2020;35(5):711â€&quot;5.32250460 152.BrownleeW, BourdetteD, BroadleyS, KillesteinJ, CiccarelliO.Treating multiple sclerosis"/>
  <result pre="and movement disorders. Mov Disord.2020;35(5):711â€&quot;5.32250460 152.BrownleeW, BourdetteD, BroadleyS, KillesteinJ, CiccarelliO.Treating" exact="multiple sclerosis" post="and neuromyelitis optica spectrum disorder during the COVID-19 pandemic."/>
  <result pre="Mov Disord.2020;35(5):711â€&quot;5.32250460 152.BrownleeW, BourdetteD, BroadleyS, KillesteinJ, CiccarelliO.Treating multiple sclerosis and" exact="neuromyelitis optica" post="spectrum disorder during the COVID-19 pandemic. Neurology2020;94(22):949â€&quot;52.32241953 153.LaiJ, MaS,"/>
  <result pre="mental health outcomes among health care workers exposed to coronavirus" exact="disease" post="2019. JAMA Netw Open. 2020;3(3):e203976.32202646 154.Mental illness, suicides rise"/>
  <result pre="Minerva Pediatr.2020;72(3):226â€&quot;35.32613821 156.DubeyS, BiswasP, GhoshR, et al.Psychosocial impact of COVID-19." exact="Diabetes" post="Metab Syndr.2020;14(5):779â€&quot;88.32526627 157.MaunderR, HunterJ, VincentL, et al.The immediate psychological"/>
  <result pre="in a teaching hospital. Cmaj. 2003;168(10):1245â€&quot;51.12743065 158.TamCW, PangEP, LamLC, ChiuHF.Severe" exact="acute" post="respiratory syndrome (SARS) in Hong Kong in 2003: stress"/>
  <result pre="a teaching hospital. Cmaj. 2003;168(10):1245â€&quot;51.12743065 158.TamCW, PangEP, LamLC, ChiuHF.Severe acute" exact="respiratory" post="syndrome (SARS) in Hong Kong in 2003: stress and"/>
  <result pre="teaching hospital. Cmaj. 2003;168(10):1245â€&quot;51.12743065 158.TamCW, PangEP, LamLC, ChiuHF.Severe acute respiratory" exact="syndrome" post="(SARS) in Hong Kong in 2003: stress and psychological"/>
  <result pre="Med Public Health Prep.2013;7(1):105â€&quot;10.24618142 161.SalluhJI, WangH, SchneiderEB, et al.Outcome of" exact="delirium" post="in critically ill patients: systematic review and meta-analysis. BMJ.2015;350:h2538.26041151"/>
  <result pre="systematic review and meta-analysis. BMJ.2015;350:h2538.26041151 162.KhandakerGM, ZimbronJ, DalmanC, LewisG, JonesPB.Childhood" exact="infection" post="and adult schizophrenia: a meta-analysis of population-based studies. Schizophr"/>
  <result pre="and meta-analysis. BMJ.2015;350:h2538.26041151 162.KhandakerGM, ZimbronJ, DalmanC, LewisG, JonesPB.Childhood infection and" exact="adult" post="schizophrenia: a meta-analysis of population-based studies. Schizophr Res.2012;139(1â€&quot;3):161â€&quot;8.22704639 163.SteinbergD,"/>
  <result pre="of population-based studies. Schizophr Res.2012;139(1â€&quot;3):161â€&quot;8.22704639 163.SteinbergD, HirschSR, MarstonSD, ReynoldsK, SuttonRN.Influenza" exact="infection" post="causing manic psychosis. Br J Psychiatry1972;120(558):531â€&quot;5.5041533 164.SeveranceEG, DickersonFB, ViscidiRP,"/>
  <result pre="international collaboration to combat mental health challenges during the Coronavirus" exact="disease" post="2019 pandemic. JAMA Psychiatry2020; doi: 10.1001/jamapsychiatry.2020.1057. 168.DubeyMJ, GhoshR, ChatterjeeS,"/>
  <result pre="Psychiatry2020; doi: 10.1001/jamapsychiatry.2020.1057. 168.DubeyMJ, GhoshR, ChatterjeeS, BiswasP, ChatterjeeS, DubeyS.COVID-19 and." exact="Diabetes" post="Metab Syndr.2020;14(5):817â€&quot;23. doi: 10.1016/j.dsx.2020.06.00832540735"/>
 </snippets>
</snippetsTree>
